NZ732534B2 - Calibrated dose control - Google Patents
Calibrated dose control Download PDFInfo
- Publication number
- NZ732534B2 NZ732534B2 NZ732534A NZ73253415A NZ732534B2 NZ 732534 B2 NZ732534 B2 NZ 732534B2 NZ 732534 A NZ732534 A NZ 732534A NZ 73253415 A NZ73253415 A NZ 73253415A NZ 732534 B2 NZ732534 B2 NZ 732534B2
- Authority
- NZ
- New Zealand
- Prior art keywords
- certain embodiments
- user
- temperature
- amount
- vaporizable material
- Prior art date
Links
- 239000000463 material Substances 0.000 claims abstract description 484
- 239000006200 vaporizer Substances 0.000 claims abstract description 222
- 239000004480 active ingredient Substances 0.000 claims abstract description 69
- 239000000126 substance Substances 0.000 claims description 74
- SNICXCGAKADSCV-JTQLQIEISA-N Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims description 73
- 229960002715 Nicotine Drugs 0.000 claims description 53
- 229930015196 nicotine Natural products 0.000 claims description 53
- 230000000875 corresponding Effects 0.000 claims description 11
- 239000000969 carrier Substances 0.000 claims description 8
- 150000002334 glycols Chemical class 0.000 claims description 3
- 230000004931 aggregating Effects 0.000 claims 2
- 238000010438 heat treatment Methods 0.000 abstract description 88
- 239000000203 mixture Substances 0.000 description 155
- 230000002149 cannabinoid Effects 0.000 description 152
- 229930003827 cannabinoid Natural products 0.000 description 152
- 239000003557 cannabinoid Substances 0.000 description 152
- 238000009472 formulation Methods 0.000 description 114
- 241000218236 Cannabis Species 0.000 description 78
- 230000036961 partial Effects 0.000 description 76
- 238000009834 vaporization Methods 0.000 description 43
- 239000007788 liquid Substances 0.000 description 39
- 230000001276 controlling effect Effects 0.000 description 34
- 230000015654 memory Effects 0.000 description 34
- 230000000391 smoking Effects 0.000 description 27
- 150000001875 compounds Chemical class 0.000 description 26
- 238000005259 measurement Methods 0.000 description 23
- 230000001186 cumulative Effects 0.000 description 19
- 239000002253 acid Substances 0.000 description 15
- 230000001007 puffing Effects 0.000 description 14
- 241000208125 Nicotiana Species 0.000 description 10
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- 239000000523 sample Substances 0.000 description 10
- BPZSYCZIITTYBL-ORAYPTAESA-N (S,S)-formoterol Chemical compound C1=CC(OC)=CC=C1C[C@H](C)NC[C@@H](O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-ORAYPTAESA-N 0.000 description 9
- 239000011149 active material Substances 0.000 description 9
- 229960002848 formoterol Drugs 0.000 description 9
- -1 nicotine compound Chemical class 0.000 description 9
- 241001076849 Aides Species 0.000 description 8
- UVOLYTDXHDXWJU-NRFANRHFSA-N Cannabichromene Natural products C1=C[C@](C)(CCC=C(C)C)OC2=CC(CCCCC)=CC(O)=C21 UVOLYTDXHDXWJU-NRFANRHFSA-N 0.000 description 8
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N Theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 239000011368 organic material Substances 0.000 description 8
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 7
- 238000004364 calculation method Methods 0.000 description 7
- 229940079593 drugs Drugs 0.000 description 7
- 238000001704 evaporation Methods 0.000 description 7
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 235000007586 terpenes Nutrition 0.000 description 7
- 229960004436 Budesonide Drugs 0.000 description 6
- VOVIALXJUBGFJZ-VXKMTNQYSA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3O[C@@H](CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-VXKMTNQYSA-N 0.000 description 6
- MGNNYOODZCAHBA-GQKYHHCASA-N Fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 description 6
- 229960001664 Mometasone Drugs 0.000 description 6
- GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 description 6
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N cinnamic aldehyde Natural products O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 6
- 229960002714 fluticasone Drugs 0.000 description 6
- QLIIKPVHVRXHRI-CXSFZGCWSA-N mometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CCl)(O)[C@@]1(C)C[C@@H]2O QLIIKPVHVRXHRI-CXSFZGCWSA-N 0.000 description 6
- 150000007524 organic acids Chemical class 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 229960004017 salmeterol Drugs 0.000 description 6
- 239000011364 vaporized material Substances 0.000 description 6
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N Cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 description 5
- 229950011318 Cannabidiol Drugs 0.000 description 5
- QHMBSVQNZZTUGM-MSOLQXFVSA-N Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@@H]1[C@@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-MSOLQXFVSA-N 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 150000001735 carboxylic acids Chemical class 0.000 description 5
- 230000002596 correlated Effects 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 244000025596 Cassia laevigata Species 0.000 description 4
- 235000006693 Cassia laevigata Nutrition 0.000 description 4
- MYKUKUCHPMASKF-VIFPVBQESA-N Nornicotine Chemical compound C1CCN[C@@H]1C1=CC=CN=C1 MYKUKUCHPMASKF-VIFPVBQESA-N 0.000 description 4
- 244000269722 Thea sinensis Species 0.000 description 4
- 229960000278 Theophylline Drugs 0.000 description 4
- 229960001948 caffeine Drugs 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 150000002338 glycosides Chemical class 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 239000002417 nutraceutical Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 150000003505 terpenes Chemical class 0.000 description 4
- GWYFCOCPABKNJV-UHFFFAOYSA-N 3-Methylbutanoic acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 3
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 3
- 229940023808 Albuterol Drugs 0.000 description 3
- 229960002028 Atropine Sulfate Drugs 0.000 description 3
- JPKKQJKQTPNWTR-CHYDPLAESA-N CHEMBL3182372 Chemical compound O.OS(O)(=O)=O.O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1.O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 JPKKQJKQTPNWTR-CHYDPLAESA-N 0.000 description 3
- QXACEHWTBCFNSA-SFQUDFHCSA-N Cannabigerol Chemical compound CCCCCC1=CC(O)=C(C\C=C(/C)CCC=C(C)C)C(O)=C1 QXACEHWTBCFNSA-SFQUDFHCSA-N 0.000 description 3
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N Diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 3
- HCFDWZZGGLSKEP-UHFFFAOYSA-N Doxylamine Chemical compound C=1C=CC=NC=1C(C)(OCCN(C)C)C1=CC=CC=C1 HCFDWZZGGLSKEP-UHFFFAOYSA-N 0.000 description 3
- 229960005178 Doxylamine Drugs 0.000 description 3
- FSBUXLDOLNLABB-RIOYCTGKSA-N Echinacoside Natural products O=C(O[C@H]1[C@H](O[C@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O2)[C@@H](O)[C@H](OCCc2cc(O)c(O)cc2)O[C@H]1CO[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)/C=C/c1cc(O)c(O)cc1 FSBUXLDOLNLABB-RIOYCTGKSA-N 0.000 description 3
- SUBDBMMJDZJVOS-UHFFFAOYSA-N Esomeprazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 3
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 3
- 229960001361 Ipratropium Bromide Drugs 0.000 description 3
- 229940087612 Levalbuterol Drugs 0.000 description 3
- NDAUXUAQIAJITI-LBPRGKRZSA-N Levosalbutamol Chemical compound CC(C)(C)NC[C@H](O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-LBPRGKRZSA-N 0.000 description 3
- OCJYIGYOJCODJL-UHFFFAOYSA-N Meclizine Chemical compound CC1=CC=CC(CN2CCN(CC2)C(C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)=C1 OCJYIGYOJCODJL-UHFFFAOYSA-N 0.000 description 3
- 229940041321 Meclizine Drugs 0.000 description 3
- 229960003987 Melatonin Drugs 0.000 description 3
- UCHDWCPVSPXUMX-TZIWLTJVSA-N Montelukast Chemical compound CC(C)(O)C1=CC=CC=C1CC[C@H](C=1C=C(\C=C\C=2N=C3C=C(Cl)C=CC3=CC=2)C=CC=1)SCC1(CC(O)=O)CC1 UCHDWCPVSPXUMX-TZIWLTJVSA-N 0.000 description 3
- CMWTZPSULFXXJA-VIFPVBQESA-N Naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 3
- VQDBNKDJNJQRDG-UHFFFAOYSA-N Pirbuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=N1 VQDBNKDJNJQRDG-UHFFFAOYSA-N 0.000 description 3
- NDAUXUAQIAJITI-UHFFFAOYSA-N Salbutamol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 3
- 229940033529 Tetrahydrocannabinol Drugs 0.000 description 3
- YEEZWCHGZNKEEK-UHFFFAOYSA-N Zafirlukast Chemical compound COC1=CC(C(=O)NS(=O)(=O)C=2C(=CC=CC=2)C)=CC=C1CC(C1=C2)=CN(C)C1=CC=C2NC(=O)OC1CCCC1 YEEZWCHGZNKEEK-UHFFFAOYSA-N 0.000 description 3
- 229960004764 Zafirlukast Drugs 0.000 description 3
- 230000002378 acidificating Effects 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 230000003213 activating Effects 0.000 description 3
- 239000000443 aerosol Substances 0.000 description 3
- 239000000556 agonist Substances 0.000 description 3
- 229930013930 alkaloids Natural products 0.000 description 3
- 229940065144 cannabinoids Drugs 0.000 description 3
- 229960001803 cetirizine Drugs 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 229940117916 cinnamic aldehyde Drugs 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 229960000520 diphenhydramine Drugs 0.000 description 3
- 229960004242 dronabinol Drugs 0.000 description 3
- FSBUXLDOLNLABB-ISAKITKMSA-N echinacoside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC(=O)\C=C\C=2C=C(O)C(O)=CC=2)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O[C@@H](OCCC=2C=C(O)C(O)=CC=2)[C@@H]1O FSBUXLDOLNLABB-ISAKITKMSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 235000009569 green tea Nutrition 0.000 description 3
- 229960001680 ibuprofen Drugs 0.000 description 3
- 230000000977 initiatory Effects 0.000 description 3
- LHLMOSXCXGLMMN-VVQPYUEFSA-M ipratropium bromide Chemical compound [Br-].O([C@H]1C[C@H]2CC[C@@H](C1)[N@@+]2(C)C(C)C)C(=O)C(CO)C1=CC=CC=C1 LHLMOSXCXGLMMN-VVQPYUEFSA-M 0.000 description 3
- ZKLPARSLTMPFCP-UHFFFAOYSA-N levocetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 description 3
- 229950008204 levosalbutamol Drugs 0.000 description 3
- 229960001474 meclozine Drugs 0.000 description 3
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 3
- 229960005127 montelukast Drugs 0.000 description 3
- 229960002009 naproxen Drugs 0.000 description 3
- 229960000381 omeprazole Drugs 0.000 description 3
- 229960005414 pirbuterol Drugs 0.000 description 3
- 230000001105 regulatory Effects 0.000 description 3
- 230000000241 respiratory Effects 0.000 description 3
- 229960002052 salbutamol Drugs 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 2
- UIKROCXWUNQSPJ-VIFPVBQESA-N (-)-cotinine Chemical group C1CC(=O)N(C)[C@@H]1C1=CC=CN=C1 UIKROCXWUNQSPJ-VIFPVBQESA-N 0.000 description 2
- JPFCOVZKLAXXOE-XBNSMERZSA-N (3R)-2-(3,5-dihydroxy-4-methoxyphenyl)-8-[(2R,3R,4R)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2H-chromen-4-yl]-3,4-dihydro-2H-chromene-3,5,7-triol Chemical compound C1=C(O)C(OC)=C(O)C=C1C1[C@H](O)CC(C(O)=CC(O)=C2[C@H]3C4=C(O)C=C(O)C=C4O[C@@H]([C@@H]3O)C=3C=CC(O)=CC=3)=C2O1 JPFCOVZKLAXXOE-XBNSMERZSA-N 0.000 description 2
- ZROLHBHDLIHEMS-HUUCEWRRSA-N (6aR,10aR)-6,6,9-trimethyl-3-propyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCC)=CC(O)=C3[C@@H]21 ZROLHBHDLIHEMS-HUUCEWRRSA-N 0.000 description 2
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 2
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 2
- MOYAFQVGZZPNRA-UHFFFAOYSA-N 1,4(8)-p-menthadiene Chemical compound CC(C)=C1CCC(C)=CC1 MOYAFQVGZZPNRA-UHFFFAOYSA-N 0.000 description 2
- KXKOBIRSQLNUPS-UHFFFAOYSA-N 1-hydroxy-6,6,9-trimethyl-3-pentylbenzo[c]chromene-2-carboxylic acid Chemical compound O1C(C)(C)C2=CC=C(C)C=C2C2=C1C=C(CCCCC)C(C(O)=O)=C2O KXKOBIRSQLNUPS-UHFFFAOYSA-N 0.000 description 2
- GRWFGVWFFZKLTI-IUCAKERBSA-N 1S,5S-(-)-alpha-Pinene Natural products CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 2
- YJYIDZLGVYOPGU-XNTDXEJSSA-N 2-[(2E)-3,7-dimethylocta-2,6-dienyl]-5-propylbenzene-1,3-diol Chemical compound CCCC1=CC(O)=C(C\C=C(/C)CCC=C(C)C)C(O)=C1 YJYIDZLGVYOPGU-XNTDXEJSSA-N 0.000 description 2
- YHXKVHQFWVYXIC-JTQLQIEISA-N 3-[(2S)-1-methylpyrrolidin-2-yl]-1-oxidopyridin-1-ium Chemical compound CN1CCC[C@H]1C1=CC=C[N+]([O-])=C1 YHXKVHQFWVYXIC-JTQLQIEISA-N 0.000 description 2
- BBNHNZGTKSWIHD-SNVBAGLBSA-N 5'-Hydroxycotinine Chemical compound CN1C(=O)CC[C@@]1(O)C1=CC=CN=C1 BBNHNZGTKSWIHD-SNVBAGLBSA-N 0.000 description 2
- HRHJHXJQMNWQTF-UHFFFAOYSA-N 5-hydroxy-2-methyl-2-(4-methylpent-3-enyl)-7-pentylchromene-6-carboxylic acid Chemical compound O1C(C)(CCC=C(C)C)C=CC2=C1C=C(CCCCC)C(C(O)=O)=C2O HRHJHXJQMNWQTF-UHFFFAOYSA-N 0.000 description 2
- 208000006673 Asthma Diseases 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- IGHTZQUIFGUJTG-UHFFFAOYSA-N Cannabicyclol Chemical compound O1C2=CC(CCCCC)=CC(O)=C2C2C(C)(C)C3C2C1(C)CC3 IGHTZQUIFGUJTG-UHFFFAOYSA-N 0.000 description 2
- WVOLTBSCXRRQFR-SJORKVTESA-N Cannabidiolic acid Natural products OC1=C(C(O)=O)C(CCCCC)=CC(O)=C1[C@@H]1[C@@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-SJORKVTESA-N 0.000 description 2
- SEEZIOZEUUMJME-VBKFSLOCSA-N Cannabigerolic acid Natural products CCCCCC1=CC(O)=C(C\C=C(\C)CCC=C(C)C)C(O)=C1C(O)=O SEEZIOZEUUMJME-VBKFSLOCSA-N 0.000 description 2
- VBGLYOIFKLUMQG-UHFFFAOYSA-N Cannabinol Chemical compound C1=C(C)C=C2C3=C(O)C=C(CCCCC)C=C3OC(C)(C)C2=C1 VBGLYOIFKLUMQG-UHFFFAOYSA-N 0.000 description 2
- 229960003453 Cannabinol Drugs 0.000 description 2
- SVTKBAIRFMXQQF-UHFFFAOYSA-N Cannabivarin Chemical compound C1=C(C)C=C2C3=C(O)C=C(CCC)C=C3OC(C)(C)C2=C1 SVTKBAIRFMXQQF-UHFFFAOYSA-N 0.000 description 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 2
- CIPULDKLIIVIER-VIFPVBQESA-N Cotinine N-oxide Chemical compound C1CC(=O)N(C)[C@@H]1C1=CC=CN(=O)=C1 CIPULDKLIIVIER-VIFPVBQESA-N 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N GABA Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- FAMPSKZZVDUYOS-PGPZXUPKSA-N Humulene Natural products C\C1=C\CC(C)(C)\C=C\C\C(C)=C/CC1 FAMPSKZZVDUYOS-PGPZXUPKSA-N 0.000 description 2
- XOKCJXZZNAUIQN-IENPIDJESA-N Hydroxycotinine Chemical compound C1C(O)C(=O)N(C)[C@@H]1C1=CC=CN=C1 XOKCJXZZNAUIQN-IENPIDJESA-N 0.000 description 2
- FXFANIORDKRCCA-UHFFFAOYSA-N Norcotinine Chemical compound N1C(=O)CCC1C1=CC=CN=C1 FXFANIORDKRCCA-UHFFFAOYSA-N 0.000 description 2
- 229920001991 Proanthocyanidin Polymers 0.000 description 2
- UCONUSSAWGCZMV-HZPDHXFCSA-N Tetrahydrocannabinolic acid Chemical compound C([C@H]1C(C)(C)O2)CC(C)=C[C@H]1C1=C2C=C(CCCCC)C(C(O)=O)=C1O UCONUSSAWGCZMV-HZPDHXFCSA-N 0.000 description 2
- BLGXFZZNTVWLAY-CCZXDCJGSA-N Yohimbine Natural products C1=CC=C2C(CCN3C[C@@H]4CC[C@@H](O)[C@H]([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-CCZXDCJGSA-N 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 229960003692 aminobutyric acid Drugs 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- WVOLTBSCXRRQFR-DLBZAZTESA-N cannabidiolic acid Chemical compound OC1=C(C(O)=O)C(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-DLBZAZTESA-N 0.000 description 2
- SEEZIOZEUUMJME-FOWTUZBSSA-N cannabigerolic acid Chemical compound CCCCCC1=CC(O)=C(C\C=C(/C)CCC=C(C)C)C(O)=C1C(O)=O SEEZIOZEUUMJME-FOWTUZBSSA-N 0.000 description 2
- NVEQFIOZRFFVFW-RGCMKSIDSA-N caryophyllene oxide Chemical compound C=C1CC[C@H]2O[C@]2(C)CC[C@H]2C(C)(C)C[C@@H]21 NVEQFIOZRFFVFW-RGCMKSIDSA-N 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000002485 combustion reaction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229940013945 gamma-Aminobutyric Acid Drugs 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 230000001976 improved Effects 0.000 description 2
- 150000001761 labdane diterpenoid derivatives Chemical class 0.000 description 2
- 230000004301 light adaptation Effects 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 150000002763 monocarboxylic acids Chemical class 0.000 description 2
- 229930014981 nornicotine Natural products 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000000779 smoke Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- BLGXFZZNTVWLAY-SCYLSFHTSA-N yohimbine Chemical compound C1=CC=C2C(CCN3C[C@@H]4CC[C@H](O)[C@@H]([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-SCYLSFHTSA-N 0.000 description 2
- 229960000317 yohimbine Drugs 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N (+-)-(RS)-limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 1
- NPNUFJAVOOONJE-ZIAGYGMSSA-N (-)-Isocaryophyllene Natural products C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 1
- NPNUFJAVOOONJE-GFUGXAQUSA-N (-)-β-caryophyllene Chemical compound C1CC(/C)=C/CCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-GFUGXAQUSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- QCUPYFTWJOZAOB-HWKANZROSA-N (E)-N-carbamoyl-2-ethylbut-2-enamide Chemical compound CC\C(=C/C)C(=O)NC(N)=O QCUPYFTWJOZAOB-HWKANZROSA-N 0.000 description 1
- BOTWFXYSPFMFNR-PYDDKJGSSA-N (E)-Phytol Chemical compound CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CO BOTWFXYSPFMFNR-PYDDKJGSSA-N 0.000 description 1
- 239000001707 (E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-ol Substances 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-Propanediol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- 229940035676 ANALGESICS Drugs 0.000 description 1
- 241000906543 Actaea racemosa Species 0.000 description 1
- 229940006211 Anticholinergic mydriatics and cycloplegics Drugs 0.000 description 1
- 229940065524 Anticholinergics inhalants for obstructive airway diseases Drugs 0.000 description 1
- 102000018208 Cannabinoid receptor family Human genes 0.000 description 1
- 108050007331 Cannabinoid receptor family Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N Carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 235000004310 Cinnamomum zeylanicum Nutrition 0.000 description 1
- 229950006073 Cotinine Drugs 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N Dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 240000001267 Echinacea angustifolia Species 0.000 description 1
- UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapen Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 description 1
- 230000005355 Hall effect Effects 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 244000169657 Hyptis suaveolens Species 0.000 description 1
- 235000004185 Hyptis suaveolens Nutrition 0.000 description 1
- 210000000088 Lip Anatomy 0.000 description 1
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium Ion Chemical group [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 description 1
- 210000004072 Lung Anatomy 0.000 description 1
- 235000005321 Marrubium vulgare Nutrition 0.000 description 1
- UAHWPYUMFXYFJY-UHFFFAOYSA-N Myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 1
- 235000008690 Pausinystalia yohimbe Nutrition 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- BOTWFXYSPFMFNR-QYLFUYDXSA-N Phytol Natural products CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C/CO BOTWFXYSPFMFNR-QYLFUYDXSA-N 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-N Salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 1
- 240000006661 Serenoa repens Species 0.000 description 1
- 235000005318 Serenoa repens Nutrition 0.000 description 1
- 240000001717 Vaccinium macrocarpon Species 0.000 description 1
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 1
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 1
- 240000006745 Valeriana officinalis Species 0.000 description 1
- 235000013832 Valeriana officinalis Nutrition 0.000 description 1
- 229940046008 Vitamin D Drugs 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
- 229930006725 alpha-pinene Natural products 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic Effects 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000001078 anti-cholinergic Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 150000001559 benzoic acids Chemical class 0.000 description 1
- 229930006719 beta-myrcene Natural products 0.000 description 1
- 230000000975 bioactive Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000009529 body temperature measurement Methods 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- 229930016253 catechin Natural products 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 235000005301 cimicifuga racemosa Nutrition 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 229930004021 citronellol Natural products 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 235000004634 cranberry Nutrition 0.000 description 1
- 230000003247 decreasing Effects 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000014134 echinacea Nutrition 0.000 description 1
- 239000003571 electronic cigarette Substances 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing Effects 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 229930003935 flavonoids Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229960002870 gabapentin Drugs 0.000 description 1
- 235000009754 grape Nutrition 0.000 description 1
- 235000012333 grape Nutrition 0.000 description 1
- 238000004442 gravimetric analysis Methods 0.000 description 1
- 229930000763 humulenes Natural products 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 125000001865 labdane diterpenoid group Chemical group 0.000 description 1
- 230000002045 lasting Effects 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 230000000670 limiting Effects 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229930007650 limonene Natural products 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 229910001416 lithium ion Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 201000003152 motion sickness Diseases 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000003237 recreational drug Substances 0.000 description 1
- 230000002829 reduced Effects 0.000 description 1
- 238000002407 reforming Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000010018 saw palmetto extract Substances 0.000 description 1
- 235000001483 serenoa repens Nutrition 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- WSWCOQWTEOXDQX-MQQKCMAXSA-N sorbic acid group Chemical group C(\C=C\C=C\C)(=O)O WSWCOQWTEOXDQX-MQQKCMAXSA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
- 230000001702 transmitter Effects 0.000 description 1
- 230000001960 triggered Effects 0.000 description 1
- 235000016788 valerian Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000002747 voluntary Effects 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
- A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
- A24F40/10—Devices using liquid inhalable precursors
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
- A24F40/50—Control or monitoring
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
- A24F40/50—Control or monitoring
- A24F40/51—Arrangement of sensors
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
- A24F40/50—Control or monitoring
- A24F40/53—Monitoring, e.g. fault detection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
- A61M11/041—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters
- A61M11/042—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters electrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
- A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
- A61M15/008—Electronic counters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
- A61M2016/0027—Accessories therefor, e.g. sensors, vibrators, negative pressure pressure meter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
- A61M2016/003—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter
- A61M2016/0033—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical
- A61M2016/0039—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical in the inspiratory circuit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/14—Detection of the presence or absence of a tube, a connector or a container in an apparatus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3327—Measuring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3368—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/581—Means for facilitating use, e.g. by people with impaired vision by audible feedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/582—Means for facilitating use, e.g. by people with impaired vision by tactile feedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/583—Means for facilitating use, e.g. by people with impaired vision by visual feedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/82—Internal energy supply devices
- A61M2205/8206—Internal energy supply devices battery-operated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/82—Internal energy supply devices
- A61M2205/8237—Charging means
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01K—MEASURING TEMPERATURE; MEASURING QUANTITY OF HEAT; THERMALLY-SENSITIVE ELEMENTS NOT OTHERWISE PROVIDED FOR
- G01K7/00—Measuring temperature based on the use of electric or magnetic elements directly sensitive to heat ; Power supply therefor, e.g. using thermoelectric elements
- G01K7/16—Measuring temperature based on the use of electric or magnetic elements directly sensitive to heat ; Power supply therefor, e.g. using thermoelectric elements using resistive elements
- G01K7/22—Measuring temperature based on the use of electric or magnetic elements directly sensitive to heat ; Power supply therefor, e.g. using thermoelectric elements using resistive elements the element being a non-linear resistance, e.g. thermistor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/0004—Gaseous mixtures, e.g. polluted air
- G01N33/0009—General constructional details of gas analysers, e.g. portable test equipment
- G01N33/0027—General constructional details of gas analysers, e.g. portable test equipment concerning the detector
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05B—ELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
- H05B1/00—Details of electric heating devices
- H05B1/02—Automatic switching arrangements specially adapted to apparatus ; Control of heating devices
- H05B1/0227—Applications
- H05B1/023—Industrial applications
- H05B1/0244—Heating of fluids
Abstract
Methods and vaporizer apparatuses that estimate, measure and/or predict the amount of vapor and/or material (including active ingredients) released by the vaporizer apparatus. In particular, described herein are electronic vaporizers and methods of using them that determine a dose/amount of vapor and/or a material in the vapor based primarily or exclusively on the electrical and thermal properties, e.g., power or energy applied to the vaporizing element (e.g., heating coil) and the temperature of the material immediately before and as it is vaporized. Dose information may be used to control operation of the device and/or reported to the user. d/or a material in the vapor based primarily or exclusively on the electrical and thermal properties, e.g., power or energy applied to the vaporizing element (e.g., heating coil) and the temperature of the material immediately before and as it is vaporized. Dose information may be used to control operation of the device and/or reported to the user.
Description
CALIBRATED DOSE CONTROL
CROSS REFERENCE TO RELATED APPLICATIONS
This application claims priority to U.S. Provisional Application No. 62/088,464 filed
December 5, 2014, titled “CALIBRATED DOSE CONTROL AND HEAT BLOCK RESERVOIR FOR
E-VAPORIZER DEVICE,” and U.S. Provisional Application No. 62/199,828, filed July 31, 2015, titled
“CALIBRATED DOSE CONTROL,” each of which is herein incorporated by reference in its entirety.
This patent application may also be related to U.S. patent application no. 14/581,666, filed
Dec. 23, 2014 and titled “Vaporization Device Systems and Methods,” which is herein incorporated by
reference in its entirety.
INCORPORATION BY REFERENCE
All publications and patent applications mentioned in this specification are herein
incorporated by reference in their entirety to the same extent as if each individual publication or patent
application was specifically and individually indicated to be incorporated by reference.
FIELD
[0004] The devices, systems and methods described herein may be useful for determining a dosage
of a vapor and/or an amount of active ingredient in the vapor to a user inhaling the vapor.
BACKGROUND
Vaporizing devices, including electronic vaporizer devices or e-vaporizer devices, allow the
delivery of vapor containing one or more active ingredient by inhalation of the vapor. Electronic
vaporizer devices are gaining increasing popularity both for prescriptive medical use, in delivering
medicaments, and for consumption of tobacco and other plant-based smokeable materials. Electronic
vaporizer devices in particular may be portable, self-contained and convenient for use. Unfortunately,
such devices, even when adapted for medical use, may vary in the amount of vapor and/or active
ingredient provided.
[0006] To date, attempts to determine the dosage of vapor and/or an active ingredient in the vapor
have been unsatisfactory. Systems that pre-determine dosage by restricting the amount of material to be
delivered in a session assume, often incorrectly, that all of the material will be inhaled, and may not be
adjustable for partial dosages. Such systems may also meter the amount of material, and require accurate
measurement of the mass and/or volume of material being delivered for vaporization, or measure the
difference between a starting mass/volume and post-delivery mass or volume. These measurements may
be difficult, requiring a high level of accuracy and expense, and may result in inaccurate results.
What is needed is a method and apparatus (e.g., system and/or device) for delivering vapor and
accurately, e.g., within a reasonable margin of accuracy/error, the delivered dosage. In particular, it
would be helpful to provide methods and apparatuses for determining delivered doses of vapor and/or
ingredients within the vapor by monitoring the electrical activity, and in some cases the temperature
(which may be estimated electrically or measured directly) of the apparatus. Further, it would be helpful
to provide such methods and apparatuses to deliver predetermined doses and/or to alert a use or caregiver
when a threshold dosage has been reached or exceeded. Further, it may also be helpful to provide an
electronic record of doses delivered.
The discussion of the background to the invention included herein including reference to
documents, acts, materials, devices, articles and the like is included to explain the context of the present
invention. This is not to be taken as an admission or a suggestion that any of the material referred to was
published, known or part of the common general knowledge in Australia or in any other country as at the
priority date of any of the claims.
SUMMARY
According to an aspect of the present invention, there is provided a method of determining an
estimated amount of a substance delivered to a user of a vaporizer device, the method comprising:
determining an amount of power applied to a heater of a vaporizer device, the heater configured to
vaporize a vaporizable material; determining a first temperature of a portion of the vaporizer device at a
first time; determining a second temperature of the portion of the vaporizer device at a second time,
subsequent to the first time; and determining, based on the amount of power applied to the heater and a
difference between the first temperature and the second temperature, the estimated amount of the
substance delivered to the user of the vaporizer device from the first time to the second time.
[0009] According to another aspect of the present invention, there is provided a vaporizer device
comprising: a heater configured to aerosolize a vaporizable material; and one or more controllers
configured to perform operations , the operations comprising: determining an amount of power applied to
the heater, the heater configured to vaporize a vaporizable material; determining a first temperature of a
portion of the vaporizer device at a first time; determining a second temperature of the portion of the
vaporizer device at a second time, subsequent to the first time; and determining, based on the amount of
power applied to the heater and a difference between the first and second temperatures, an estimated
amount of a substance delivered to a user from the first time to the second time.
Disclosed herein are methods and apparatuses, including devices and systems that may
estimate, measure and/or predict the amount of vapor and/or material (including active ingredients) in the
vapor that can be delivered to a user. In particular, described herein are electronic vaporizers and
methods of using them that determined a dose/amount of vapor and/or a material in the vapor based
primarily or exclusively on the electrical properties, e.g., power or energy applied to the vaporizing
element (e.g., coil) and, in some variations, the temperature of the material as it is vaporized. In some
variations the temperature of the material as it is being vaporized may be estimated/approximated based
on the electrical properties, e.g., the temperature coefficient of resistance or TCR, of the vaporizing
element.
In general, the methods and apparatuses described herein may accurately determine the
dosage delivered to within about 20% of an actual dosage delivered (e.g., within about 19%, within about
18%, within about 17%, within about 16%, within about 15%, within about 14%, within about 13%,
within about 12%, within about 11%, within about 10%, etc.).
[0012] Also described herein are methods and apparatuses for calibrating. Calibration may be
performed automatically or manually, and may be performed at the factory. In some variations,
calibration may be performed by the user. Calibration may include the input of values, including constant
values. Calibration may be performed when the material being vaporized, including either or both the
carrier and/or the active ingredient, are changed.
[0013] Although many of the examples described herein are directed to determining dosage of
nicotine or other tobacco-related materials, it should be understood that these methods and apparatuses
may be used for delivery and dosage determination of any vaporizable material, including therapeutic
drugs. Examples of active ingredients that may be used as described herein are provided below, and may
include botanicals, nutraceuticals, pharmaceuticals, and the like, including combinations of these. The
methods and apparatuses described herein may provide relatively pure material directly to the lungs,
which may speed the action in the body, including both the time of onset and the off-time.
In some embodiments, disclosed herein are methods and devices that allow a user to control
the amount of vapor generated from a vaporizable material. This allows for customization of the vaping
experience for a variety of vaporizable materials, and an overall improved user experience. The methods
of this disclosure can be implemented using any electronic vaporizer device or vaporizing device
configured as specified herein.
For example, the present disclosure provides a method of dose control and calibration of
electronic vaporizer devices comprising measuring the amount of material vaporized from a vaporizable
material from an electronic vaporizer device or vaporizing device relative to power, time and temperature.
These methods and apparatuses may include a vaporized dose (e.g. mass) prediction system comprising
setting-up a relationship of total particulate matter (TPM) or active ingredient vaporization or release as a
function of temperature (which may be determined by electrical resistivity or otherwise measured by a
temperature-proportionate property), time (which may be associated with detection of puffing/inhalation
by the user) and power consumption of the vaporizing element(s). In some embodiments, the present
disclosure provides a method of metered dose control and calibration of electronic vaporizer devices
comprising measuring the amount of material vaporized from a vaporizable material from an electronic
vaporizer device or vaporizing device relative to power and temperature; particularly, a method
comprising a vaporized dose prediction system comprising setting-up a relationship of total particulate
matter (TPM) or active ingredient vaporization or release as a function of temperature and power
consumption.
Thus, described herein are methods of determining a dose of a vaporizable material delivered
to a user of a vaporizing device over a time period. The time period typically comprises a plurality of
sequential time intervals. In any of these methods and apparatuses the vaporizing device may include a
heater controller, a heater, a source of the vaporizable material and a vaporized dose predictor unit. For
example, a method may include: calculating, for each of the sequential time intervals, a partial dose,
wherein the partial dose is calculated from a power delivered by the heater controller to the heater to
vaporize the vaporizable material during a partial dose time interval, a temperature of the vaporizable
material being vaporized during the partial dose time interval, and a temperature of the vaporizable
material being vaporized before the partial dose time interval; and summing the calculated partial doses in
the vaporized dose predictor unit to determine a total dose of vapor delivered during the time period.
Any of the calculation or summing steps may be performed in the device (e.g., locally, e.g.,
within a controller which may include or be part of the vaporized dose predictor unit that is within the
same housing as other portions of the device such as the heater control), and/or they may be performed
remotely, e.g., in a processor that receives, such as wirelessly, the power, temperature(s) and/or partial
dose information. The vaporized dose predictor unit (which may be referred to herein as a vaporized
dose predictor or vaporized dose predictor circuitry, or vaporized dose predictor control logic) may be
located remotely from other portions of the device, including in a remote server (e.g., cloud-based server,
smartphone or wearable apparatus, etc.) and may receive the information wirelessly.
In general, any of these methods may also include determining an amount of active ingredient
delivered to the user based on the total dose of vapor delivered. This may be performed using the
concentration of active material within the source of vaporizable material, for example (e.g., giving the
amount of active ingredient/unit mass or unit volume or the vaporizable material in the source of
vaporizable material).
Any of these methods may also include determining a change in temperature (ΔT) of the
vaporizable material being vaporized for each of the sequential time intervals relative the temperature of
the vaporizable material being vaporized.
Any appropriate time interval (dose time interval), which may be sequential (e.g., sequential
time intervals) may be used, and may be based on or reflective of the sampling rate of the apparatus for
determining the dose. For example, the time interval may be between about 200 msec and about 10 msec.
The calculation of dose may also include calculating, for each of the sequential time intervals,
a partial dose that is further based upon a latent heat and a specific heat of the material. For example, as
described in greater detail herein, constants may be empirically or theoretically (e.g., from the latent heat
and/or specific heat of the material being vaporized) and may be initially provided to the devices
described herein, or may be periodically updated (e.g., in a calibration step) the any of these devices.
In general, the calculations of partial dose (vapor mass) being delivered by the device may be
based on the mass/energy balance in the material being vaporized by balancing the energy put into the
material by the heater (e.g., joule heating coil), including the change in energy due to evaporation, the
change in heat as it is absorbed by the material to be vaporized, and the energy lost from the system via
heat transfer. As described by the inventors herein, this may be expressed with surprising accuracy in
terms of the energy (power) applied to the heater and the temperature just before and during/after
vaporization of the vaporizable material. Variations in the structure of the vaporizer (heater shape,
material, size, etc.) and the material being vaporized may be accounted for as constants and ignored (e.g.,
providing a unit-less or self-referencing value). For example, the steps of calculating, for each of the
sequential time intervals, a partial dose may include subtracting from a first constant times the power
delivered by the heater controller to the heater to vaporize the vaporizable material during the partial dose
time interval, a second constant times the temperature of the vaporizable material being vaporized during
the partial dose time interval and a third constant times the temperature of the vaporizable material being
vaporized before the partial dose time interval. Alternatively, the steps of calculating, for each of the
sequential time intervals, a partial dose may include subtracting from a first constant times the power
delivered by the heater controller to the heater to vaporize the vaporizable material during the partial dose
time interval, a different second constant times the difference between the temperature of the vaporizable
material being vaporized during the partial dose time interval and the temperature of the vaporizable
material being vaporized before the partial dose time interval, and a different third constant times the
temperature of the vaporizable material being vaporized before the partial dose time interval.
In general, calculating a partial dose may use the temperature of the vaporizable material
being vaporized during the partial dose time interval and the temperature of the vaporizable material
being vaporized before the partial dose time interval comprises using an electrical property of the heater
that is proportional to the temperature of the heater as the temperature of the vaporizable material being
vaporized during the partial dose time interval. Thus, the temperature referred to in any of the calculation
steps described herein (e.g., the temperature of the vaporizable material being vaporized during the partial
dose time interval and the temperature of the vaporizable material being vaporized before the partial dose
time interval) may refer to any value that is proportional to the actual temperature (e.g., using a
temperature coefficient of resistance value to determine a value proportionally related to temperature,
without requiring the conversion (using constants determined from the system to convert to °C or °F).
In general the methods and apparatuses described herein may implement the resulting dose
information (or partial, running or summed dose information), e.g., to report and/or control operation of
the apparatus or transmit to a secondary (e.g., remote) apparatus. For example, any of these methods may
also include alerting the user when the total dose of vapor delivered during the time period meets or
exceeds a preset threshold. Any of these methods may also include disabling the device when the total
dose of vapor delivered during the time period meets or exceeds a preset threshold. Any of these methods
(or devices configured to implement them) may further include calculating and displaying a cumulative
total dose of vapor delivered over a session period that includes the time period. Thus, the total running
dose over multiple puffs (each puff may be considered a time period, or the time period may an entire
session in which the apparatus is turned on for vaporizing the material, or multiple on periods until reset
by the user).
[0025] In general, any of these methods may include detecting a user’s puff on the vaporizer device,
wherein the time period corresponds to a duration of the detected user’s puff.
Any appropriate material to be vaporized (vaporizable material) may be used. In general, the
vaporizable material may be a liquid. The vaporizable material may comprise any active ingredient(s).
For example, the vaporizable material may comprise a tobacco-based material. The vaporizable material
may comprise a botanical. The vaporizable material may comprise a nicotine compound. The vaporizable
material may comprise a cannabinoid. The vaporizable material may comprise one or more of: cetirizine,
ibuprofen, naproxen, omeprazole, doxylamine, diphenhydramine, melatonin, or meclizine. The
vaporizable material may comprise one or more of: albuterol, levalbuterol, pirbuterol, salmeterol,
formoterol, atropine sulfate, ipratropium bromide, fluticasone, budesonide, mometasone, montelukast,
zafirlukast, theophylline, fluticasone and salmeterol, budesonide and formoterol, or mometasone and
formoterol. The vaporizable material may comprise one or more of: a polyphonel, a green tea catechin,
caffeine, a phenol, a glycoside, a labdane diterpenoid, yohimbine, a proanthocyanidin, terpene glycoside,
an omega fatty acid, echinacoside, an alkaloid, isovaleric acid, a terpene, gamma-aminobutyric acid, a
senna glycoside, cinnamaldehyde, or Viamin D. The vaporizable material may comprise a nicotine salt,
glycerin, and propylene glycol.
As mentioned, the vaporized dose predictor unit may be part of a controller. In some
variations, both the vaporized dose predictor and the heater controller are part of the same controller. In
some variations the vaporized dose predictor and the heater controller are separate.
Another example of the methods of determining a dose of a vaporizable material delivered to
a user of a vaporizing device over a time period as described herein (e.g., wherein the time period
comprises a plurality of sequential time intervals, and wherein the vaporizing device includes a heater
controller, a heater, a source of the vaporizable material and a vaporized dose predictor unit) may include:
transmitting a power delivered by the heater controller to the heater at each of the plurality of sequential
time intervals from the power controller to the vaporized dose predictor unit; calculating, for each of the
sequential time intervals, a partial dose, wherein the partial dose is calculated from the power delivered
by the heater controller to the heater to vaporize the vaporizable material during each of the plurality of
sequential time intervals, a temperature of the vaporizable material being vaporized during each of the
plurality of sequential time intervals, and a temperature of the vaporizable material being vaporized
before each of the plurality of sequential time intervals; and summing the calculated partial doses in the
vaporized dose predictor unit to determine a total dose of vapor delivered during the time period.
Any of these methods may also include transmitting the temperature of the vaporizable
materials being vaporized during each of the plurality of sequential time intervals from the power
controller to the vaporized dose predictor unit.
Another example of a method of determining a dose of a vaporizable material delivered to a
user of a vaporizing device over a time period (e.g., wherein the time period comprises a plurality of
sequential time intervals, and wherein the vaporizing device includes a heater controller, a heater, a
source of the vaporizable material including an active ingredient, and a vaporized dose predictor unit)
may include: calculating, for each of the sequential time intervals, a partial dose, wherein the partial dose
is calculated from a power delivered by the heater controller to the heater to vaporize the vaporizable
material during a partial dose time interval, a temperature of the vaporizable material being vaporized
during the partial dose time interval, and a temperature of the vaporizable material being vaporized
immediately before the partial dose time interval; summing the calculated partial doses in the vaporized
dose predictor unit to determine a total dose of vapor delivered during the time period; and determining
an amount of active ingredient delivered to the user based on the total dose of vapor delivered.
A method of determining an amount of vapor delivered to a user of a vaporizing device may
include: measuring an amount of power delivered from a power source of the vaporizer device over a first
period of time; measuring a temperature of a material being vaporized in the vaporizer device over the
first period of time; and determining an amount of vapor delivered to the user during the first period of
time based upon the measured amount of power and a change in the measured temperature during the first
period of time.
[0032] Any of these methods may also include detecting an amount of active ingredient delivered to
the user based upon the determined amount of vapor. The measuring step may be performed at any
appropriate frequency, such as a frequency of between 5 Hz and 50 Hz within the first period of time. The
measuring steps may be performed at a frequency of between 10Hz and 30Hz within the first period of
time.
[0033] As mentioned above, determining the amount of vapor delivered to the user during the first
period of time may be further based upon a latent heat and a specific heat of the material.
In any of these methods, determining the amount of vapor delivered to the user during the
first period of time comprises calculating based upon the formula:
Δm = ∑ a[Pi − b(T − T ) − cT ]
vap,cumulative i i−1 i
where Δm , is the total amount of vapor delivered to the user, a is a constant, b is a constant, c is
vap cumulative
a constant, P is the measured power, and T is the measured temperature from the first period of time, and
T is a measured temperature from an immediately preceding time period.
Any of these methods may also include alerting the user when the determined amount of
vapor delivered to the user meets or exceeds a preset vapor threshold, and/or disabling the device when
the determined amount of vapor meets or exceeds a preset vapor threshold.
Any of these methods may also include detecting a user’s puff on the vaporizer device,
wherein the measuring steps are performed only during the detected puff.
As mentioned above, in any of the methods described herein, appropriate material to be
vaporized (vaporizable material) may be used. In general, the vaporizable material may be a liquid. The
vaporizable material may comprise any active ingredient(s). For example, the vaporizable material may
comprise a tobacco-based material. The vaporizable material may comprise a botanical. The vaporizable
material may comprise a nicotine compound. The vaporizable material may comprise a cannabinoid. The
vaporizable material may comprise one or more of: cetirizine, ibuprofen, naproxen, omeprazole,
doxylamine, diphenhydramine, melatonin, or meclizine. The vaporizable material may comprise one or
more of: albuterol, levalbuterol, pirbuterol, salmeterol, formoterol, atropine sulfate, ipratropium bromide,
fluticasone, budesonide, mometasone, montelukast, zafirlukast, theophylline, fluticasone and salmeterol,
budesonide and formoterol, or mometasone and formoterol. The vaporizable material may comprise one
or more of: a polyphonel, a green tea catechin, caffeine, a phenol, a glycoside, a labdane diterpenoid,
yohimbine, a proanthocyanidin, terpene glycoside, an omega fatty acid, echinacoside, an alkaloid,
isovaleric acid, a terpene, gamma-aminobutyric acid, a senna glycoside, cinnamaldehyde, or Viamin D.
The vaporizable material may comprise a nicotine salt, glycerin, and propylene glycol.
Also described herein are vaporization apparatuses, such as devices and systems, configured
to determine a dose of the vapor being delivered. For example, a vaporizer device may include: a heater
controller; a heater coupled to the heater controller so that the heater controller applies power to the
heater; a source of vaporizable material; and a vaporized dose predictor unit receiving input from the
heater controller, wherein the vaporized dose predictor is configured to determine a dose of vapor
delivered to a user during a time period based upon: an amount of power delivered by the heater
controller to the heater to vaporize the vaporizable material during each of a plurality of partial dose time
intervals within the time period, a temperature of the vaporizable material being vaporized during each
partial dose time interval, and a temperature of the vaporizable material being vaporized before each
partial dose time interval.
Any of these devices may also include an output configured to present the amount of vapor
delivered by the user during the time period.
Any appropriate output may be used, including a video display, LED, speaker, wireless
transmitter, etc. Any of the apparatuses described herein may include a temperature sensor configured to
sense a temperature of the vaporizable material being vaporized during each partial dose time interval.
As described herein, the temperature sensor may be a separate and/or dedicated (e.g., thermistor) or it
may determine the temperature (e.g., of the heater and/or the material being heated) based on the relative
resistance of the heater itself.
As mentioned, the vaporized dose predictor unit may include a controller. For example, the
vaporized dose predictor unit may be integral with the heater controller. The vaporized dose predictor
may be configured to determine the amount of vapor delivered as dose of vapor delivered. The vaporized
dose predictor may be configured to determine an amount of active ingredient delivered to the user based
on the dose of vapor delivered.
In any of the apparatuses described herein, the partial dose time intervals may each be
between about 200 msec and about 10 msec.
The vaporized dose predictor unit may be configured to calculate, for each of the partial dose
time intervals, a partial dose by subtracting from a first constant times the power delivered by the heater
controller to the heater to vaporize the vaporizable material during the partial dose time interval, a second
constant times the temperature of the vaporizable material being vaporized during the partial dose time
interval and a third constant times the temperature of the vaporizable material being vaporized before the
partial dose time interval.
In general, the vaporized dose predictor unit may be configured to determine the amount of
vaporizable material delivered to the user.
As described herein, the vaporized dose predictor unit is configured to use an electrical
property of the heater that is proportional to the temperature of the heater as the temperature of the
vaporizable material being vaporized during the partial dose time interval.
Any of these apparatuses may include an alarm configured to alert the user when the total
dose of vapor delivered during the time period meets or exceeds a preset threshold. Any of these
apparatuses may include dose control logic configured to disable the device when the total dose of vapor
delivered during the time period meets or exceeds a preset threshold.
Any of these apparatuses may also include a puff detector configured to detect a user puffing
on the device. In some variations, the vaporized dose predictor unit may be configured to set the time
period as a duration of a detected user’s puff (e.g., between 0.5-15 sec, between 0.5 – 20 sec, between 0.5
to 10 seconds, etc.).
The source of vaporizable material may be a liquid or a solid or a gel. The vaporizable
material is preferably a liquid.
Other methods and apparatus variations are also described. For example, described herein
are methods for quantifying and controlling an amount of a vapor and/or one or more material(s) within
the vapor that is delivered to a user from a reservoir of vaporizable material in an electronic vaporizer
device. The electronic vaporizer device may include a puff sensor, a power source (e.g., battery,
capacitor, etc.), a heating element controller, and a heating element. A separate temperature sensor may
also be included, or it may be part of the heating element controller, which may estimate temperature of
the heating element (e.g., resistive coil, etc.) based on a change in resistance due to temperature (e.g.,
TCR), and may therefore include a reference resistor. One or more additional temperature sensors may
also be included. These apparatuses may also include a vaporized dose predictor unit, which may be
separate from (and may receive inputs from) the temperature controller or it may be integrated with it. In
some variations the apparatus also includes an alert unit and/or a controlling logic for controlling
operation of the apparatus based on the determined/estimated dosage (e.g., turning off, triggering an alert,
etc.).
For example, a method of operating the device may include: (optionally) a puff sensor
detecting a user’s puff, the heating element controller measuring an amount of power delivered from the
power source during the user’s puff (e.g., at multiple discrete time intervals during the puff); the
temperature sensor measuring a temperature or a temperature profile of the material being vaporized (e.g.,
at or near the heating element) during the user’s puff; the vaporized dose predictor calculating the amount
of the vapor delivered to the user from the vaporizable material based upon the amount of the power and
the temperature during the user’s puff, or based upon the amount of the power and the temperature profile
during the user’s puff; and a) engaging the alert unit to alert the user when the amount of the vapor
delivered meets or exceeds a preset vapor amount threshold for the user’s puff, or when a cumulative
amount of the vapor delivered from a plurality of puffs meets or exceeds a preset vapor amount threshold,
or b) implementing the controlling logic to disable or modify an output of one or more features of the
electronic vaporizer device when the amount of the vapor delivered meets or exceeds a preset vapor
amount threshold for the user’s puff, or when a cumulative amount of the vapor delivered from a plurality
of puffs meets or exceeds a preset vapor amount threshold, or c) both a) and b). In certain embodiments,
the method comprises storing a plurality of measurements of temperature, temperature profiles, amount of
power delivered, or a combination thereof, in a memory unit. In certain embodiments, the method
comprises adjusting the preset vapor amount threshold from one puff to the next, based on the amount of
the vapor delivered to the user by the user’s prior puff. In certain embodiments, the electronic vaporizer
device comprises a timer, and the method may comprise engaging the timer to measure a puff duration.
In certain embodiments, the method comprises storing a plurality of measurements of temperature,
temperature profiles, amount of power delivered, puff duration or a combination thereof in a memory
unit. In certain embodiments, the method comprises normalizing the amount of the vapor delivered to the
user to the puff duration. In certain embodiments, the method comprises attaching a separate pod to the
device, the separate pod configured to hold a vaporizable material. In certain embodiments, the method
comprises calculating the amount of the vapor delivered to a user from the vaporizable material in
milligrams of total particulate matter. In certain embodiments, the method comprises calculating the
amount of the vapor delivered to a user from the vaporizable material in milligrams of an active
ingredient. In certain embodiments, the method comprises adjusting the preset vapor amount threshold. In
certain embodiments, the electronic vaporizer device comprises a heating reservoir distinct from the
heating element, and the method comprises preheating a vaporizable material to a preset temperature. In
certain embodiments, the vaporizable material is a liquid, viscous liquid, wax or loose-leaf material. In
certain embodiments, the vaporizable material is a tobacco-based material. In certain embodiments, the
vaporizable material is a botanical. In certain embodiments, the vaporizable material is a medicinal
compound. In certain embodiments, the vaporizable material is nicotine. In certain embodiments, the
vaporizable material is a cannabinoid. In certain embodiments, the vaporizable material is Cannabis. In
certain embodiments, the method comprises adjusting a type of the vaporizable material. In certain
embodiments, the method comprises adjusting the type of the vaporizable material to a liquid, viscous
liquid, wax or loose-leaf material. In certain embodiments, the method comprises adjusting the type of the
vaporizable material to a tobacco-based material. In certain embodiments, the method comprises
adjusting the type of the vaporizable material to a botanical. In certain embodiments, the method
comprises adjusting the type of the vaporizable material to a medicinal compound. In certain
embodiments, the method comprises adjusting the type of the vaporizable material to nicotine. In certain
embodiments, the method comprises adjusting the type of the vaporizable material to a cannabinoid. In
certain embodiments, the method comprises adjusting the type of the vaporizable material to Cannabis.
Adjusting the vaporizable material may include adjusting the apparatus or method to account for the
change in constants and/or calibrating the apparatus to account for changes in the constants that may be
used to give a calibrated (e.g., mass or mass/time) output, as described in greater detail herein.
In certain embodiments, the alert unit comprises a piezoelectric speaker, and the method
comprises alerting the user by activating the piezoelectric speaker to produce an audible sound when the
amount of the vapor delivered to the user meets or exceeds the preset vapor amount threshold. In certain
embodiments, the alert unit comprises a light emitting diode, and the method comprises alerting the user
by illuminating the light emitting diode when the amount of the vapor delivered to the user meets or
exceeds the preset vapor amount threshold. In certain embodiments, the alert unit comprises a vibration
motor, and the method comprises alerting the user by activating the vibration motor when the amount of
the vapor delivered to the user meets or exceeds the preset vapor amount threshold. In certain
embodiments, the controlling logic comprises a software module. In certain embodiments, the controlling
logic comprises a hardware element. In certain embodiments, the electronic vaporizer device comprises a
display unit, wherein the method comprises providing feedback to the user via the display. In certain
embodiments, the electronic vaporizer device is a single-use electronic vaporizer device. In certain
embodiments, the electronic vaporizer device is provided to an analytical smoking machine.
In a certain embodiment provided herein, is an electronic vaporizer device configured to
quantify and control an amount of a vapor delivered to a user from a vaporizable material in the electronic
vaporizer device, wherein the electronic vaporizer device comprises: a puff sensor configured to detect a
user’s puff; a heating element controller configured to measure an amount of power delivered from a
power source during the user’s puff; a temperature sensor configured to measure a temperature or a
temperature profile generated by a heating element during the user’s puff; a vaporized dose predictor unit
configured to calculate the amount of the vapor delivered to the user from the vaporizable material based
upon the amount of the power and the temperature during the user’s puff or based upon the amount of the
power and the temperature profile during the user’s puff; and one or more of a) an alert unit configured to
alert the user when the amount of vapor delivered meets or exceeds a preset vapor amount threshold for
the user’s puff, or when a cumulative amount of the vapor delivered from a plurality of puffs meets or
exceeds a preset vapor amount threshold, and b) a controlling logic configured to automatically disable
one or more feature of the electronic vaporizer device when the amount of the vapor delivered meets or
exceeds a preset vapor amount threshold for the user’s puff, or when a cumulative amount of the vapor
delivered from a plurality of puffs meets or exceeds a preset vapor amount threshold, or c) both a) and b).
In certain embodiments, the electronic vaporizer device comprises a memory unit, configured to store a
plurality of measurements of temperature, temperature profile, power delivered, or a combination thereof.
In certain embodiments, the electronic vaporizer device comprises a timer configured to determine a puff
duration. In certain embodiments, the electronic vaporizer device comprises a memory unit, configured to
store a plurality of measurements of temperature, temperature profile, power delivered, puff duration or a
combination thereof. In certain embodiments, the electronic vaporizer device is configured to normalize
the amount of the vapor delivered to the user to the puff duration. In certain embodiments, the electronic
vaporizer device comprises a separate pod attached to the device, the separate pod configured to hold a
vaporizable material. In certain embodiments, the electronic vaporizer device is configured to calculate
the amount of the vapor delivered to the user from a vaporizable material in milligrams of total particulate
matter. In certain embodiments, the electronic vaporizer device is configured to calculate the amount of
the vapor delivered to the user from a vaporizable material in milligrams of total particulate matter. In
certain embodiments, the electronic vaporizer device is configured to allow adjustment of the preset vapor
amount threshold. In certain embodiments, the electronic vaporizer device comprises a heating reservoir
distinct from the heating element. In certain embodiments, the electronic vaporizer device comprises a
vaporizable material that is a liquid, viscous liquid, wax or loose-leaf material. In certain embodiments,
the electronic vaporizer device comprises a vaporizable material that is a tobacco-based material. In
certain embodiments, the electronic vaporizer device comprises a vaporizable material that is a botanical.
In certain embodiments, the electronic vaporizer device comprises a vaporizable material that is a
medicinal compound. In certain embodiments, the electronic vaporizer device comprises a vaporizable
material that is nicotine. In certain embodiments, the electronic vaporizer device comprises a vaporizable
material that is a cannabinoid. In certain embodiments, the electronic vaporizer device comprises a
vaporizable material that is Cannabis. In certain embodiments, the electronic vaporizer device is
configured to allow adjustment of a type of the vaporizable material. In certain embodiments, the type of
the vaporizable material is adjustable to a liquid, viscous liquid, wax or loose-leaf material. In certain
embodiments, the type of the vaporizable material is adjustable to a tobacco-based material. In certain
embodiments, the type of the vaporizable material is adjustable to a botanical. In certain embodiments,
the type of the vaporizable material is adjustable to a medicinal compound. In certain embodiments, the
type of the vaporizable material is adjustable to nicotine. In certain embodiments, the type of the
vaporizable material is adjustable to a cannabinoid. In certain embodiments, the type of the vaporizable
material is adjustable to Cannabis. In certain embodiments, the alert unit comprises a piezoelectric
speaker. In certain embodiments, the alert unit comprises a light emitting diode. In certain embodiments,
the alert unit comprises a vibration motor. In certain embodiments, the controlling logic comprises a
software module. In certain embodiments, the controlling logic comprises a hardware element. In certain
embodiments, the electronic vaporizer device comprises a display unit, configured to provide feedback to
the user. In certain embodiments, the electronic vaporizer device is a single-use electronic vaporizer
device. In certain embodiments, the electronic vaporizer device is a vaporizing device.
[0053] In a certain embodiment provided herein, is a method, the method comprising an electronic
vaporizer device configured to quantify and control an amount of a vapor delivered to a user from a
vaporizable material in the electronic vaporizer device, wherein the electronic vaporizer device
comprises: a puff sensor configured to detect a user’s puff; a heating element controller configured to
measure an amount of power delivered from a power source during the user’s puff; a temperature sensor
configured to measure a temperature or a temperature profile generated by a heating element during the
user’s puff; a vaporized dose predictor unit configured to calculate the amount of the vapor delivered to
the user from the vaporizable material based upon the amount of the power and the temperature during
the user’s puff or based upon the amount of the power and the temperature profile during the user’s puff;
and one or more of a) an alert unit configured to alert the user when the amount of vapor delivered meets
or exceeds a preset vapor amount threshold for the user’s puff, or when a cumulative amount of the vapor
delivered from a plurality of puffs meets or exceeds a preset vapor amount threshold, and b) a controlling
logic configured to automatically disable one or more feature of the electronic vaporizer device when the
amount of the vapor delivered meets or exceeds a preset vapor amount threshold for the user’s puff, or
when a cumulative amount of the vapor delivered from a plurality of puffs meets or exceeds a preset
vapor amount threshold, or c) both a) and b). In certain embodiments, the electronic vaporizer device
comprises a memory unit, configured to store a plurality of measurements of temperature, temperature
profile, power delivered, or a combination thereof. In certain embodiments, the electronic vaporizer
device comprises a timer configured to determine a puff duration. In certain embodiments, the electronic
vaporizer device comprises a memory unit, configured to store a plurality of measurements of
temperature, temperature profile, power delivered, puff duration or a combination thereof. In certain
embodiments, the electronic vaporizer device is configured to normalize the amount of the vapor
delivered to the user to the puff duration. In certain embodiments, the electronic vaporizer device
comprises a separate pod attached to the device, the separate pod configured to hold a vaporizable
material. In certain embodiments, the electronic vaporizer device is configured to calculate the amount of
the vapor delivered to the user from a vaporizable material in milligrams of total particulate matter. In
certain embodiments, the electronic vaporizer device is configured to calculate the amount of the vapor
delivered to the user from a vaporizable material in milligrams of total particulate matter. In certain
embodiments, the electronic vaporizer device is configured to allow adjustment of the preset vapor
amount threshold. In certain embodiments, the electronic vaporizer device comprises a heating reservoir
distinct from the heating element. In certain embodiments, the electronic vaporizer device comprises a
vaporizable material that is a liquid, viscous liquid, wax or loose-leaf material. In certain embodiments,
the electronic vaporizer device comprises a vaporizable material that is a tobacco-based material. In
certain embodiments, the electronic vaporizer device comprises a vaporizable material that is a botanical.
In certain embodiments, the electronic vaporizer device comprises a vaporizable material that is a
medicinal compound. In certain embodiments, the electronic vaporizer device comprises a vaporizable
material that is nicotine. In certain embodiments, the electronic vaporizer device comprises a vaporizable
material that is a cannabinoid. In certain embodiments, the electronic vaporizer device comprises a
vaporizable material that is Cannabis. In certain embodiments, the electronic vaporizer device is
configured to allow adjustment of a type of the vaporizable material. In certain embodiments, the type of
the vaporizable material is adjustable to a liquid, viscous liquid, wax or loose-leaf material. In certain
embodiments, the type of the vaporizable material is adjustable to a tobacco-based material. In certain
embodiments, the type of the vaporizable material is adjustable to a botanical. In certain embodiments,
the type of the vaporizable material is adjustable to a medicinal compound. In certain embodiments, the
type of the vaporizable material is adjustable to nicotine. In certain embodiments, the type of the
vaporizable material is adjustable to a cannabinoid. In certain embodiments, the type of the vaporizable
material is adjustable to Cannabis. In certain embodiments, the alert unit comprises a piezoelectric
speaker. In certain embodiments, the alert unit comprises a light emitting diode. In certain embodiments,
the alert unit comprises a vibration motor. In certain embodiments, the controlling logic comprises a
software module. In certain embodiments, the controlling logic comprises a hardware element. In certain
embodiments, the electronic vaporizer device comprises a display unit, configured to provide feedback to
the user. In certain embodiments, the electronic vaporizer device is a single-use electronic vaporizer
device. In certain embodiments, the electronic vaporizer device is a vaporizing device.
BRIEF DESCRIPTION OF THE DRAWINGS
The novel features of the invention are set forth with particularity in the description. Like
numbers refer to like elements throughout the description of the figures. A better understanding of the
features and advantages of the present invention will be obtained by reference to the following detailed
description that sets forth illustrative embodiments, in which the principles of the invention are utilized,
and the accompanying drawings (also “figure” and “FIG.” herein), of which:
is a schematic of a vaporizing apparatus including a vaporized dose
estimation/prediction unit.
FIGS. 1B-1D shows one example of a vaporizing apparatus as described herein, in cross-
sectional, side and top views, respectively.
is an example of an exemplary apparatus able to determine the amount of material
vaporized by the device.
[0058] illustrates the accuracy of the methods and apparatuses for estimating/predicting vapor
dosage as described herein, showing a comparison of the dose estimated as described herein (solid line)
compared to actual measured dose delivered (circles).
is a table showing a comparison between actual measured dosage (total particulate
matter, or TPM, vaporized) and the dosage predicted as described herein based on discrete estimates at
multiple time intervals during a puff (inhalation) using the power applied to the vaporization element
(heater) and the temperature of the vaporization element or the temperature of the material being
vaporized at the start and finish of each of the multiple time intervals.
is another table comparing measured and estimated doses (in TPM) during a trail in
humans using one variation of the methods described herein.
[0061] FIGS. 5 and 6 graphically illustrate the relationship between applied power at a vaporizer
heater, temperature of the heater, and an estimated evaporation rate (dose) at a 35 cc and 70cc control
“puff”, respectively.
schematically illustrates one example of a heater (atomizer) and vaporizable material
reservoir for forming a vapor as described herein. In this example the heater includes a wick connected to
the reservoir and a heating element in contact with the wick; the wick and heating element extend in an
airflow path for drawing out the vapor formed. In this example, the walls of the reservoir are heated.
is a graph illustrating the number of puffs relative to the TPM release content (mg) of
a non-heated reservoir of an electronic vaporizer device compared with the number of puffs relative to the
TPM release content (mg) of a heat reservoir of an electronic vaporizer device having a heated reservoir
(“tank”).
is a table illustrating one variation of a look-up table that can be used to estimate the
amount of vapor inhaled by a user based upon calibration data.
graphically illustrates data such as that shown in , which may be used to
estimate the amount of vapor inhaled by a user.
schematically illustrates one method of determining a dose of vapor over a time
interval as described herein.
DETAILED DESCRIPTION
The present disclosure provides a method for quantifying and controlling an amount of a
vapor delivered to a user from a vaporizable material in an electronic vaporizer device comprising
measuring the vaporizable material intake evaporated, aerosolized or vaporized from a vaporizable
material in a vaporizing device or electronic vaporizer device relative to power consumed during
vaporization and temperature produced during vaporization. Also provided in this disclosure are
calibration methods that may include establishing a relationship of total particulate matter (TPM)
vaporized from a vaporizable material as a function of temperature generated and power consumed.
Calibration may be performed one time (e.g., at a factory) or it may be performed by the user.
Alternatively or additionally, the user may be requested or required to perform a calibration step that
include inputting an identifier of the material be vaporized (e.g., selecting or inputting the material and/or
concentration, or a reference identified, such as a lot number or the like that can be linked to the material
being vaporized). For example, a user may scan (e.g., using a QR code, bar code, or equivalent) the
vaporizable material or packing and/or inserts affiliated with the vaporizable material. In some variations
the apparatus includes a look-up table corresponding to a variety of vaporizable materials that may
include values for calibrating the apparatus, including the constants referred to herein that may be used to
calibrate the mass of the vapor and/or one or more components (e.g., active agents/active ingredients) in
the vaporizable material.
The term “vape” or “vaping”, as used herein, refers to the action of or the experience of using
a vaporization device, such as an electronic vaporizer device for the delivery of vapor to a user.
The term “puff” refers to the process of removing vapor from a vaporization device or e-
vaporizer device using a suction mechanism. In certain embodiments, the suction mechanism is a user. In
certain embodiments, the suction mechanism is an analytical smoking machine. Commonly used
synonyms for puff are drag, draw, hit, suck, pull, inhale, or smoke for example.
[0070] As used herein a dose may refer to the amount or quantity of the vapor and/or material (e.g.,
active ingredient(s), etc.) taken at a particular time. The dose may be quantified as a mass, or a
mass/time, depending on the context. The dose may be dose/puff.
The term “puff duration” as used herein, refers to a length of time during which a
vaporization device or electronic vaporizer device is coupled to a suction mechanism. In certain
embodiments, the suction mechanism is a user. In certain embodiments, the suction mechanism is an
analytical smoking machine. In certain embodiments, suction is provided through a mouthpiece.
The term “puff volume” as used herein, refers to a volume leaving a vaporizer device (e.g.
standard reference vaporizer device, test vaporizer device, electronic vaporizer device, or vaporization
device.). The volume can comprise one or more gas, solid, and/or liquid species. The puff volume can
comprise an amount in ml (or cc) of air or aerosol drawn through a device, for example, either an
analytical smoke machine or an electronic vaporizer device.
The term “puff frequency” as used herein refers to a number of puffs in a certain time period.
In certain embodiments, the puff frequency is calculated using a mean number of puffs per a unit of time
that is milliseconds, seconds, minutes or hours. In certain embodiments, the puff frequency is calculated
using 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10 consecutive puffs. In certain embodiments, the puff frequency is
calculated using 10, 20, 30, 40, 50, 60, 70, 80, 90, or 100 consecutive puffs. In certain embodiments, the
puff frequency is 1 puff every 1 second. In certain embodiments, the puff frequency is 1 puff about every
2 seconds. In certain embodiments, the puff frequency is 1 puff about every 3 seconds. In certain
embodiments, the puff frequency is 1 puff about every 4 seconds. In certain embodiments, the puff
frequency is 1 puff about every 5 seconds. In certain embodiments, the puff frequency is 1 puff about
every 6 seconds. In certain embodiments, the puff frequency is 1 puff about every 7 seconds. In certain
embodiments, the puff frequency is 1 puff about every 8 seconds. In certain embodiments, the puff
frequency is 1 puff about every 9 seconds. In certain embodiments, the puff frequency is 1 puff every 10
seconds. In certain embodiments, the puff frequency is 1 puff about every 15 seconds. In certain
embodiments, the puff frequency is 1 puff about every 20 seconds. In certain embodiments, the puff
frequency is 1 puff about every 25 seconds. In certain embodiments, the puff frequency is 1 puff about
every 30 seconds. In certain embodiments, the puff frequency is 1 puff about every 35 seconds. In certain
embodiments, the puff frequency is 1 puff about every 40 seconds. In certain embodiments, the puff
frequency is 1 puff about every 45 seconds. In certain embodiments, the puff frequency is 1 puff about
every 50 seconds. In certain embodiments, the puff frequency is 1 puff about every 55 seconds. In certain
embodiments, the puff frequency is 1 puff about every 60 seconds.
The term “total particulate matter (TPM) ”, as used herein, refers to an amount of matter
removed from an organic material by evaporation, vaporization or aerosolization by puffing on vaporizer
or electronic vaporizer device; and as used herein, can be synonymous to the phrase “mass vaporized”, or
“mass aerosolized”, or “m ” or “evaporated mass.”
[0075] The term "analytical smoking machine", as used herein refers to a tool that can puff on a
cigarette or vaporizer device with a specified and controlled puff volume and duration.
The term “vaporizable material”, as used herein, refers to a formulation of material, including
in particular an organic material or botanical that is placed in a vaporization device, electronic vaporizer
device, or pod (or a proprietary container) that houses the formulation. The vaporizable material can be a
liquid, oil, or wax. In certain embodiments, the vaporizable material is a loose leaf substance. In certain
embodiments, the vaporizable material can contain medicinal properties that ameliorate symptoms of a
medical condition. In certain embodiments, the vaporizable material can contain a recreational drug.
As used herein, the term “vapor” refers to the output of a vaporizer device, including a
chemical compound or mixture of chemical compounds in the gas phase or as an aerosol.
The term “memory unit,” as used herein, refers to a non-transitory computer readable
medium, software or algorithm for data storage. In certain embodiments, a memory unit is a solid state
device. In certain embodiments, a memory unit is internal to the device. In certain embodiments, a
memory unit stores data in random access memory (RAM). In certain embodiments, a memory unit is a
hard disk, tape drive, or other external device. In certain embodiments, a memory unit refers to a device
configured as a permanent holding place for digital data, until purposely erased. A memory unit also
refers to devices configured as non-volatile memory chips such as flash, Read-Only memory (ROM)
and/or Electrically Erasable Programmable Read-Only Memory (EEPROM).
The term “adjusting,” as used herein, may refer to choosing a pod, choosing an operating
parameter, choosing a type of a vaporizable material, choosing a dosage in an amount of TPM, an amount
of an active ingredient, or a percentage, ratio or fraction of TPM or an active ingredient, and/or may refer
to calibrating the apparatus.
[0080] The term “nicotine” as used herein refers to nicotine, nicotine salts of organic acid, and
common nicotine derivatives such as; norcotinine, nornicotine, nicotine N-oxide, cotinine N-oxide, 3-
hydroxycotinine and 5-hydroxycotinine.
The term “cannabinoid” refers to plant based or synthetic chemical compounds capable of
acting on cannabinoid receptors and inducing a biological effect. Cannabinoids include acids, salts, and
bioactive stereo isomers.
The term “Cannabis” refers to plants of the genus Cannabis and loose-leaf products or
extracts thereof.
In general, described herein are methods for quantifying and, in some variations, controlling
an amount of a vapor delivered to a user from a vaporizable material in an electronic vaporizer device. In
some variations, the electronic vaporizer device comprises (optionally): a puff sensor, a power source, a
heating element controller, a heating element, a temperature sensor, a vaporized dose predictor unit, an
alert unit and/or a controlling logic. A method for quantifying and/or controlling may include:
(optionally) a puff sensor detecting a user’s puff, the heating element controller measuring an amount of
power delivered from the power source during the user’s puff; the temperature sensor measuring a
temperature or a temperature profile generated by the heating element during the user’s puff; the
vaporized dose predictor unit calculating the amount of the vapor delivered to the user from the
vaporizable material based upon the amount of the power and the temperature during the user’s puff, or
based upon the amount of the power and the temperature profile during the user’s puff; and a) engaging
the alert unit to alert the user when the amount of the vapor delivered meets or exceeds a preset vapor
amount threshold for the user’s puff, or when a cumulative amount of the vapor delivered from a plurality
of puffs meets or exceeds a preset vapor amount threshold, or b) implementing the controlling logic to
disable or modify an output of one or more features of the electronic vaporizer device when the amount of
the vapor delivered meets or exceeds a preset vapor amount threshold for the user’s puff, or when a
cumulative amount of the vapor delivered from a plurality of puffs meets or exceeds a preset vapor
amount threshold, or c) both a) and b).
As will be apparent when described in greater detail below, the puff sensor is not necessary;
the apparatus and methods described herein will simply return a zero value for the dose delivered when
the user is not puffing, since the vaporizer will not form the vapor in the absence of puffing. In addition,
the methods described may be considered generally discrete, in that the estimation of vapor dose is
performed at discrete intervals forming partial doses that may later be added up to form the overall dose
delivered. This configuration may, in part, allow these methods and apparatuses to function with
surprising accuracy despite highly variable puffing durations and profiles.
[0085] Also provided herein are electronic vaporizers configured to quantify and/or control an
amount of a vapor delivered to a user from a vaporizable material in the electronic vaporizer device,
wherein the electronic vaporizer device may comprise any of: (optionally) a puff sensor configured to
detect a user’s puff; a heater controller (also referred to as a heating element controller) configured to
determine an amount of power delivered from a power source during the user’s puff; a temperature sensor
(which may be a direct sensor such as a thermistor, or it may be a temperature sensing unit that
determines the temperature, e.g., of the heater, based on electrical properties of the heater) configured to
determine a temperature or a temperature profile generated by a heating element during the user’s puff; a
vaporized dose predictor (also referred to as a vaporized dose predictor unit or circuitry) that calculates
the amount of the vapor delivered to the user from the vaporizable material based upon the power applied
to the heater and the temperature of the heater (which may be an estimate of the temperature of the
vaporizable material as it is vaporized) during a user’s puff, or based upon the amount of the power and
the temperature profile during the user’s puff; and one or more of: a) an alert unit configured to alert the
user when the amount of vapor delivered meets or exceeds a preset vapor amount threshold for the user’s
puff, or when a cumulative amount of the vapor delivered from a plurality of puffs meets or exceeds a
preset vapor amount threshold, and b) a disabling unit configured to automatically disable one or more
feature of the electronic vaporizer device when the amount of the vapor delivered meets or exceeds a
preset vapor amount threshold for the user’s puff, or when a cumulative amount of the vapor delivered
from a plurality of puffs meets or exceeds a preset vapor amount threshold, or c) both a) and b).
is a schematic illustration of one example of an electronic vaporization device 100’
including a vaporized dose predictor unit 109. In general any of the vaporizer apparatuses described
herein may include a heater controller 105, a heater 106, a source of vaporizable material 103, a power
source (e.g., battery, not shown), and a vaporized dose predictor unit 109. The vaporized dose predictor
unit 109 may include a clock 119 and/or a memory (memory unit) 117, or these elements may be part of
an overall circuitry including a processor 110 which communicates with the vaporized dose prediction
unit.
The heater may be any appropriate heater, including resistive heaters such as a resistive coil.
The heater is typically coupled to the heater controller so that the heater controller applies power (e.g.,
from the power source) to the heater. The heater controller may include regulatory control logic to
regulate the temperature of the heater by adjusting the applied power. The heater controller may include
a dedicated or general-purpose processor, circuitry, or the like and is generally connected to the power
source and may receive input from the power source to regulate the applied power to the heater. The
controller forming or including the heater controller may also include additional controllers/processors
and executing logic 110, such as the vaporized dose predictor unit, alert/alarm logic, and/or temperature
detector/sensor 107, or these components may be separate.
Any a source of vaporizable material may be used, including a reservoir (e.g., well, pod,
cartridge, or the like), which includes the material to be vaporized. The material to be vaporized may
include a carrier and one or more active ingredients, as discussed in greater detail herein.
[0089] In general, the vaporized dose predictor unit is configured to divide up a time period (e.g.,
during a single puff) into a plurality of sequential time intervals, which may be referred to as partial dose
intervals, and determine the partial dose (or mass) of vapor produced during each partial dose interval.
The vaporized dose predictor unit may then sum these up to determine the actual dose produced and
presumably delivered to the user. Thus, the device, including the vaporized dose predictor unit may
include a timer or clock 117 and can generate intervals of any appropriate duration within a time period
(e.g., between 10 msec and 200 msec). Thus, the vaporized dose predictor unit may sample at a
frequency related to the duration of the time intervals (e.g., between 5 Hz and 100 Hz, etc., between 5 Hz
and 120 Hz, between 5 Hz and 140 Hz, between 5 Hz and 150 Hz, between 5 Hz and 180 Hz, between 5
Hz and 200 Hz, between 5 Hz and 300 Hz, etc.). The vaporized dose predictor unit generally bases the
calculation of each partial dose on input from the heater controller, which may include the power applied
before or at the start of each partial dose interval. The vaporized dose predictor unit also receives an input
proportional to the temperature at the start and at the end of each partial dose interval (e.g., the
temperature or a value proportional to the temperature at the end of the immediately previous partial dose
interval). In variations in which the temperature is an average value for each dose interval, the vaporized
dose predictor unit may receive the temperature (or a proportional value) for a dose interval and the
temperature (or a proportional value) of the dose interval immediately preceding it. The vaporized dose
predictor unit may then use this applied power and temperature information to calculate the dose (e.g.,
mass) of vapor during that interval, as will be described in greater detail below. These interval values
(dose interval values) may be summed over the entire time period to determine the overall dose of vapor
generated; the vaporized dose predictor unit may also then convert this dose of vapor to a dose of an
active ingredient in the vapor, by, e.g., converting based on the concentration of active ingredient in the
vaporizable material. U.S. patent application no. 14/581,666, filed Dec. 23, 2014 and titled
“Vaporization Device Systems and Methods,” previously incorporated by reference in its entirety, also
describes vaporizers including methods and apparatuses for temperature measurement and control similar
to that described above.
As mentioned above, in some variations the temperatures for the vaporizable material being
vaporized by the device are determined from the heater, without requiring an additional sensor. For
example, the relative change in resistance of the heater (e.g., the temperature coefficient of resistivity)
may be used, along with a reference resistor, to approximate the temperature of the heater. Although a
conversation factor may be used to convert the ratio of heater resistivity and reference resistivity to an
actual temperature value, in some variations the system, and particularly the vaporized dose predictor
unit, may use the proportional value directly, without multiplying by a conversion factor. These values
are therefore “proportional” to the temperature. For example, any of these apparatuses may include logic
for determining the temperature of the heater based on the TCR. The resistance of the heater (e.g., a
resistive heater) may be measured (R ) during operation of the apparatus as well as the resistance of a
heater
reference (R ) resistor separate from the heater. The ratio of the heater resistance to the reference
reference
resistance (R /R ) is linearly proportional with the temperature (above room temp) of the heater,
heater reference
and may be directly converted to a calibrated temperature. For example, a change in temperature of the
heater relative to room temperature may be calculated using an expression such as (R /R – 1)*
heater reference
(1/TCR), where TCR is the temperature coefficient of resistivity for the heater. In one example, TCR for
a particular device heater is 0.00014. In determining the partial doses and doses described herein, the
temperature value used (e.g., the temperature of the vaporizable material during a dose interval, T ,
described in more detail below) may refer to the unitless resistive ratio (e.g., Rheater/Rreference) or it may
refer to the normalized/corrected temperature (e.g., in °C).
Thus, the vaporized dose predictor unit may be configured to determine a dose of vapor
delivered to a user during a time period based upon: an amount of power delivered by the heater
controller to the heater to vaporize the vaporizable material during each of a plurality of partial dose time
intervals within the time period, a temperature of the vaporizable material being vaporized during each
partial dose time interval, and a temperature of the vaporizable material being vaporized before each
partial dose time interval. As just mentioned, the temperature of the vaporizable material being vaporized
may refer to an input that is proportional to the temperature.
Other optional features shown in may include a puff sensor 113 and/or dose output
115. The puff sensor typically detects the application of a puff by the user, and may include a pressure
sensor, flow sensor, or contact sensor (e.g., lip contact sensor). A dose output may include any
appropriate output, including a visual output (e.g., LED, monitor, etc.), audio output (buzzer, tone, etc.),
tactile output (vibrator, etc.), or the like. The dose output may act as an alarm or alert to the user, e.g.,
when a dose threshold has been reached.
[0093] FIGS. 1B-1D show an exemplary compact electronic vaporizer device assembly 100, such as
an electronic cigarette, medical inhaler, or other inhalation device, for generating an inhalable aerosol.
The compact electronic device 100 can include a device body 200 with a cartridge receptacle 210 for
receiving a cartridge 300 or a “pod” that can be removably inserted into the device body 200. A
mouthpiece 310 allows the user to puff on the device to inhale material aerosolized by the device.
[0094] The device body 200 can include a power source 230, such as a rechargeable battery, a
printed circuit board (PCB) 240 containing a microcontroller with the operating logic and software
instructions for the device, and a puff sensor 270 for sensing when the user is drawing vapor from the
device.
The cartridge 300 can include a heater 360 and a material storage compartment 320
configured to store the material to be vaporized. The heater 360 may be powered by the power source
230. In this example, the heater 360 may be used as a temperature sensor as described above and herein,
e.g., using the temperature coefficient of resistance (TCR) and a reference resistance. Alternatively or
additionally, a separate temperature sensor (e.g., thermistor, etc.) that is in thermal contact with the heater
and/or vaporizable material may be used. The temperature sensor may, in general, be configured to
measure a temperature of a vaporizable material within the heater 360. The temperature of the heater
may be controlled by the microcontroller of the PCB 240.
The device 100 (or any other vaporizable device) can include on-board processing configured
to determine an amount of material vaporized and delivered to the user.
shows a flowchart that represents another exemplary vaporizer apparatus capable of
determining the amount of material vaporized within the apparatus (device 100). As shown, the power
source 230, heater 360, temperature sensor 250, and puff sensor 270 are communicatively coupled to a
control unit 10 (which can be part of one or more printed circuit board(s) 240 shown in FIGS. 1B-1D).
[0098] The control unit 10 can include a heating element controller 4, vaporized mass predictor
(VMP or VMP unit, which may be a type of vaporized dose estimation/prediction unit) 8, and a memory
unit 11. In some embodiments, a user interface 13 on the device can provide the user with information
related to the device, such as the amount of vapor inhaled. An interface controller 12 within the control
unit can be configured to control the user interface 13. In a certain embodiment, the device additionally
comprises an alert unit.
To determine an amount of vapor received by the user, the control unit 10 can relay a
temperature reading 7 and a power reading 5 during a puff (which can be determined by the puff sensor
) to the VMP unit 8, which can calculate a predicted vaporized mass 9. In certain embodiments, the
VMP unit 8 relays the predicted vaporized mass 9 to the memory unit 11. In certain embodiments, the
VMP unit 8 relays the predicted vaporized mass to the user interface controller 12. In a certain
embodiment, the processor comprises a controlling logic 14 that relays instructions to the heating element
controller 4. In a certain embodiment, the method comprises activating an alert unit.
Calculation of vaporizable material vaporized – Exemplary Method
[0100] In a certain embodiment, the amount of vapor generated from a vaporizable material within a
vaporizing device, such as device 100, can be calculated from the power supplied to a vaporizable
material by a power source, and the temperature generated during vaporization. In some embodiments,
the amount of vapor generated from a vaporized material can be calculated as a function of energy
consumed and temperature generated during vaporization. That is, the power consumed by the power
source (such as power source 240), as set by the heater controller (though in some variations it could be
measured from the heater or power source) and the temperature of the vaporized material (such as within
the chamber 32), as measured by a temperature sensor (such as temperature sensor 250) can be used to
determine the amount of vapor generated and/or inhaled.
In some embodiments, the total mass vaporized can be predicted or determined based upon
equation 1:
� =�
= ∑ � [� − � (� − � ) − � � ] (equation 1)
��� ,���������� � � � −1 �
� =1
where Δm is the total mass vaporized during sampling intervals i=1 to i = n, each interval
vap,cumulative
being of a fixed time increment; P is power supplied during interval i; a, b, and c are constants; T is
temperature reading for interval i; T is temperature reading for interval immediately before the current
interval (i-1 immediately prior to interval i). Note that in some variations, the temperature may be
temperature relative to room (or starting) temperature and may be expressed as � ′ (e.g.,� ′, � ′, etc.)
� � � −1
[0102] An alternative expression of this relationship may be described as:
� =�
∑ [ ]
= � � − � � − � � (equation 2)
��� ,���������� � � � −1
� =1
In this example, different coefficient may be used (e.g., d, e); this expression may be more
simply implemented using a microcontroller than equation 1, as it has fewer arithmetic functions
required, though it is mathematically equivalent.
[0104] The coefficients a, b, and c may reflect physical constants whose values can be determined
experimentally and can vary depending on the vaporizable material used. For example, the constants a, b,
and c can depend upon the latent heat and the specific heat of the material being vaporized. The constants
can further depend upon the overall mass of the system that needs to be heated (such as the liquid material
and the heater, e.g., a wick and coil). In one exemplary embodiment described below, a is equal to 0.025,
b is equal to 367, and c is equal to 30. In another embodiment, a can be equal to 0.18, b can be equal to
2000, and c can be equal to 50. These constants may be determined empirically or based on theoretical
values knowing the dimensions and material properties of the vaporizable material and heater.
For example, in some embodiments, the coefficients a, b, and c can be determined by
collecting an amount of data and running a mathematical algorithm. For example, an analytical inhalation
or smoking machine can be used to test the vaporizing device under one or more conditions. Total
particulate matter (TPM) can be collected from the vaporizing device using the analytical inhalation or
smoking machine. In some cases, the TPM can be collected on a filter pad. The filter pad can be
weighed before and after TPM is collected on the filter such that the weight of the TPM on the filter can
be determined. In some embodiments, the empirical determination of (a, b and c) is accomplished by
measuring power and temperature over a series of puffs and measuring the cumulative mass lost by the
device for those puffs gravimetrically. The mass lost by the device is taken as being equal to total
delivered mass of TPM (mg). Best values for a, b, and c are then determined by fitting the above
equation to the experimental mass delivery, power and temperature data. Adjustments in the constants
(e.g., a, b, c or a, d, e) can be made to accommodate the variance in the type of the device and of the
formulation.
One example of a method for determining the values of the constants associated with the
relationship between the mass of vapor emitted, power applied to vaporize the material during a particular
time interval (e.g., portion of a puff) and the temperature of the material before and after vaporization
during that period is described below. In this example, the device may be first weighed. Then, a series of
puffs may be taken while logging the power (e.g., at a sampling frequency such as 20 Hz, e.g. between 5
Hz and 100 Hz, 5 Hz and 200 Hz, etc.) and the temperature through the duration of the trial. The device
may then be weighed again. This may be repeated many times (e.g., more than 5, 10, 15, 20, 25, 30, 35,
40, 45, 50, 60, 70, 80, 90, 100, 120, 150, 200, etc., or between 5 and 1000, between 10 and 500, between
and 200, etc.) to achieve a sufficiently sized data set. In one example, the process is repeated 29 times.
The m_vap may then be calculated for each sample by subtracting the final mass from the initial mass.
Alternatively, the mass of the vapor may be directly measured, e.g., by applying the vapor onto a filter
pad and use the change in mass of the pad to get m_vap; this may be less accurate because some of the
vapor might go through the pad or deposit on other surfaces. For simple gravimetric analysis, measuring
the device may be preferred.
After collecting all the data, the m_vap estimates, as well as a set of values for temp and
power over the duration for each sample may then be used to solve for the constants. For example, in
equation (1), the constants a, b, and c may be determined from this data. Alternative expression of the
equation (e.g., see equation 2, described below) may be used. For example, the values of a, b, and c may
be determined such that SUM[t=1 to t=n](aP - b(T - T ) - cT ) may be solved to find the best fit to the
i i-1 i
m_vap that was measured for each sample. As mentioned, this may be performed for any expression of
the vapor mass, applied power and temperatures measured. In some variations this may be performed
using a gradient descent algorithm, to fit the data to the appropriate equation. A gradient descent
algorithm may be beneficial because is computationally cheap to find the optimal values of the constants
(e.g., a, b, and c) such that error is minimized. However, any appropriate curve-fitting algorithm or
method may be used. In this first example, three different constants are fit to a rather large dataset.
In some embodiments, the time interval i (e.g., the partial dose time interval) can be between
20ms and 200ms (e.g., less than 200 msec, 180 msec, 150 msec, 120 msec, 100 msec, 90 msec, 80 msec,
70 msec, 60 msec, 50 msec, 40 msec, 30 msec, 20 msec, 10 msec, etc.). The temperature and power
measurements can be taken at a frequency of between 5 and 50Hz, such as between 10 and 30Hz, such as
at approximately 20Hz.
In general, the power to may refer to power delivered to heat the vaporizable material (e.g., in
some variations, the power applied by the heater controller to the heater) to vaporize the vaporizable
material during a partial dose time interval. The power applied may be read directly from the heater
controller (e.g., a watts, joules, joules/sec , volts*volts, volts*volts/resistance, etc.) and/or may be sensed,
e.g., using any appropriate power sensor (voltmeter, hall effect sensor, inductive sensor, direct
measurement sensor, voltage response measurement sensor, etc.). The power may be detected either
immediately before or during the time interval (e.g., partial dose interval), representing the power applied
to vaporize the material during that interval. For example, the power used to determine a partial dose
may be transmitted from the heater controller simultaneous with applying the power to the heater; in
some variations the power (P ) is the power applied during the interval immediately before the interval i
(e.g., i-1) because this power is then absorbed by the vaporizable material during the dose interval being
measured. Alternative, when the power (P ) may be the power sensed directly or indirectly during the
relevant dose interval (i).
Similarly, the temperature measured may be the temperature of the vaporizable material
being vaporized during the partial dose time interval (T ). This may be sensed directly or indirectly
during, at the start and/or at the end of the dose interval. For intervals that are sufficiently brief, this
distinction may be irrelevant. The temperature of the vaporizable material being vaporized before the
partial dose time interval may refer to the dose from the immediately prior time interval (e.g., T ), which
may also be the temperature at the start, end or during the prior time interval. Alternatively, in some
variations the temperature of the of the vaporizable material being vaporized before the partial dose time
interval may refer to the temperature of the material to be vaporized immediately before the Pi is applied
(e.g., at the start or just before the start, of the application of power); the temperature of the vaporizable
material being vaporized during the partial dose time interval may refer to the temperature of the material
at the end of the interval application of power.
[0111] The temperature and power applied to the material to be vaporized typically refers to the
temperature and power applied to the portion of the material (e.g., the material on the wick in some
variations) that will end up reforming into a vapor through the application of the energy, e.g., near the
surface, rather than the bulk of the material to be vaporized.
In some embodiments, the temperature and power readings can be gathered only when a
user’s puff is detected, such as through puff sensor 270. Detection of the user’s puff can thus activated
the microcontroller to begin calculating the amount of vapor drawn, while detection of the end of the
user’s puff can cause the microcontroller to stop calculating the amount of vapor drawn. Thus, in some
embodiments, equation 1 can be integrated over the duration of a puff. In other embodiments, the
measurements can be taken continuously and integrated over the duration of time that the device is on. In
yet another embodiment, the integration time period can be pre-set or user selected.
In some embodiments, the TPM can be adjusted to determine the total amount of a particular
compound inhaled, such as the total amount of an active ingredient, such as nicotine. For example, the
TPM can be multiplied by the percentage of active ingredient in the vaporizable material, as described
further below.
[0114] illustrates this first method of determining a vapor dose over a time interval as just
described. For example, in the time period for determining the dose (t ) may be initially set or
started 1000. The start of the time period may be triggered by the user, physician or other party (e.g.,
manually) or it may automatically start, e.g., when a user begins puffing on the vaporizer (e.g., using a
puff sensor). The duration of the time period may also be predetermined (e.g., fixed, e.g., at 2 sec, 3 sec,
4 sec, 5 sec, 6 sec, 7 sec, 8 sec, 9 sec, 10 sec, 11 sec, 12 sec, 13 sec, 14 sec, 15 sec, 16 sec, 17 sec, 18 sec,
19 sec, 20 sec, 25 sec, 30 sec, 35 sec, 40 sec, 45 sec, 50 sec, 55 sec, 60 sec, 1.5 min, 2 min, 3 min, 4 min,
min, 10 min, 12 min, 15 min, 20 min, 30 min, 1 hr, 2 hr, 3hr, 4 hr, 5 hr, 6 hr, 7 hr, 8 hr, 9hr, 10hr, 11hr,
12 hr, etc.) or it may be variable, including set by the use or it may be determined by sensing the end of a
puff. In some variations, the time period is set as the start of a session so that the total dose is determined
for the entire session, which may include multiple puffs. In some variations, each puff is considered a
time period (e.g., using a puff sensor); the dose may be determined per puff, or it may be aggregated over
all of the puffs in a session (where a session may be defined as within a particular time window, e.g., 5
minutes, 10 minutes, 20 minutes, 30 minutes, 1 hour, 2 hours, etc.).
The time period typically includes a number of time intervals i (also referred to herein as
partial dose time intervals), which divide the time up in to discrete sample periods for which a partial dose
may be calculated. The number of time intervals (n) may be predetermined, when the time period is
fixed, or it may be open (e.g., continuously incremented). The duration of the time intervals may be
fixed or variable, though they are typically fixed. The duration may be, for example, between about 200
msec and about 10 msec. The time intervals may be immediately adjacent to each other (e.g., in real
time), or they may be separated by an off period. The time intervals may generally be considered
sequential.
For each time interval, a partial dose of vaporizable material (e.g., vapor, including any active
ingredients) may be calculated. This may be controlled and/or performed by a vaporized dose predictor
(e.g., VMP unit) portion of the apparatus (or in communication with the apparatus), as described above.
During each time increment, i, the apparatus may store the temperature of the heater and/or the
vaporizable material near the heater, from the previous time interval, T 1010. This temperature value
(T ) may reflect the temperature of the material to be vaporized during this time interval and may
therefore be the temperature at the very start (or just before the very start) of the time interval. During
each time interval the apparatus controls the power applied to the heater for that interval (i) 1020. Note
that when power is not being applied to heat heater, the power value may be zero; if the heater is still at a
different temperature than the previous time increment (i-1), then there may still be vapor produced, if not
then little vapor may be produced. The power controller (heater controller) may transmit the power that
is causing to be delivered to the heater to the vaporized dose predictor.
The apparatus may also transmit the temperature of the heater and/or the vaporizable material
to be vaporized (e.g., the material near the heater) during the time interval (T ) to the vaporized dose
predictor 1030.
The system may then determine (e.g., using the vaporized dose predictor) a partial dose
estimate for the current time interval, i, using the power applied to the heater and the temperature
immediately prior to the interval (T )and the temperature during the interval (T ) 1040. For example,
i-1 i
either equations 1 or 2, discussed above, may be implemented by the vaporized dose predictor. The
partial dose estimate may be stored (e.g., separately as a discrete datum, or added to a cumulative dose for
the time period, or both), along with any of the information (P , T , etc.). The vaporized dose predictor
may include one or more memories (e.g., memory registers) for storing these values (note that the T in
the current interval may become the T during the next interval.
At the end of each time interval, the apparatus may check to see if the end of the time period
has been reached, either because of a predetermined number of intervals (n) has been reached (i=n) or
because of some other triggering event (e.g., the end of a puff, end of a session, etc.), or both. If not, then
the system may move onto the next interval, incrementing the interval (i=i+1) 1050. Once the end has
been reached, in some variations (e.g., where a cumulative register has not been kept), all of the partial
doses may be added 1060. Note that in any of these variations, this step of adding all of the partial doses
may be done in an ongoing manner, e.g., accumulating them (summing them) as each new interval is
passed. Thus, the step of summing the calculated partial doses in the vaporized dose predictor unit to
determine a total dose of vapor delivered during the time period may be done either at the end of the time
period or it may be done during the duration of the time period, as the partial doses are determined.
Examples
and 3 show a relationship of predicted TPM using equation 1 and actual readings of
TPM, using an inhalation or smoking machine. The graph of shows the relationship of predicted
TPM (solid line) and measured TPM (dots) for the machine trials. In this trial, the R-squared is 0.78.
To gather the data for Figures 2 and 3, an inhalation or smoking machine was set up using an
e-vaporizer device loaded with a separate detachable pod holding a vaporizable material. Two devices
were arranged in series. Measurement for temperature and power were collected. Ten puffs were taken
with the inhalation or smoking machine (at 55cc/3sec). The mass loss (or TPM loss) was measured every
ten puffs. 31 sample readings were collected using two prototype electronic vaporizer device devices and
four prototype pods. The data collected for power and temperature were analyzed. A comparison of the
power and temperature data were compared to actual measured mass loss data to correlate the evaporation
rate to energy consumption and temperature. It was found that with an R = 0.78, twenty-nine (29)
samples fell within ±15% and the remaining two (2) samples fell within ±17%. shows a graphical
relationship of the total particulate mass (TPM), predicted and the measured values. shows the full
data set of predicted values against the actual readings.
[0122] In the example shown in by performing the vaporized mass prediction formula
according to equation 1 as described herein, the tabular and graphical relationship of predicted TPM (mg)
to actual TPM (mg) can be established. The vaporized mass prediction formula can be utilized to create a
program that can be utilized by the VMP unit. The values can be transmitted to the calibrating device
through a wireless or wired data transfer, and more preferably can be embedded directly into the
vaporizing device itself. The results of the smoking experiment shown in can provide information
to and permit the user, or other individual, to control the amount of vaporizable material correlated to the
TPM level.
The results in Figures 2 and 3 demonstrate that equation 1 can advantageously improve over
inconsistencies that can arrive when function-fitting and/or assuming that the puffing duration and/or
power to mass removal can be correlated.
A smoking test by human subjects was also conducted using electronic vaporizer devices
configured with separate detachable pods holding vaporizable material. The criteria for the human
subjects included a voluntary participation of users, who already smoked or vaped, either regularly or
habitually, a diversity in smoking patterns or random puffing habits. Participants were asked to puff
normally, and a wide variety of puffing behaviors were observed from subject to subject and even
between puffs from the same subject. Thus, participants’ puffing attributes were variable and included
puffing from 1 to 5 mg per puff; e.g., for some subject’s puffs were consistently approximately 3 mg,
while others were 2 mg in one puff and 4 mg in the next. The table of shows the measured TPM
for human trials. The first column shows % error from target (which was 40 mg). The second column
shows error from mean, which can be a metric for further adjustment of the vaporized mass prediction
formula. The formulations of vaporizable materials in the proprietary pods can contain 40 mg of total
liquid, which can correspond to 2 mg of nicotine (5% nicotine by mass). The test shows that calibration of
the device can accurately portion a dose that can be of a specific metered dose. Here, the smoking test
was run with eleven human subjects. The twenty-three sample readings (or results) fall within ±15% of
the 40 mg target. The other two samples are within ±17%. The mean of the samples taken is 42.1 mg.
Coefficient of variance is 5.96%. All samples fall within ±11% of the mean.
In some embodiments, merely measuring a puff duration can result in inaccurate quantitation
of a vaporized mass. and show graphs that correlate TPM, as a function of power, time and
temperature. In performing the vaporized mass prediction method as described herein, where upon a
relationship of TPM (mg) as a function of power, time and temperature can be established.
In an aspect, in and the present disclosure illustrates the real-time graph
program capturing mass vaporized (mg) as a function of power, time and temperature. In and 6, the thickest line 501, 501’ (labeled temperature) is given by the resistance ratio that (R /R )
heater reference
that is proportional to the temperature of the heater (show subtracted from 1); this may multiplied by
1/TCR to convert to units (e.g.,°C), for example. Thus, in calculating the dose, the temperature (T and T
i i-
) determined for each interval is the measured resistance of the coil and baseline is a baseline resistance
(established separate from the heater, presumably at room temperature). The temperature rise is linear
with temperature rise above room temperature by a factor of 1/TCR, where TCR is the temperature
coefficient of resistance. In both and the line of medium thickness 502, 502’ (labeled
power) is power delivered to the coil (e.g., in watts). Further, in both and the thinnest line
503, 503’ (labeled evaporation rate) is evaporation (vaporization) rate, in this example in mg/msec. This
may be derived by implementing a formula such as expressed in equation 1 or equation 2, previously
discussed. The values in this example may be divided by 50ms/sample (the interval time) to arrive at
mg/msec instead of mg/sample. This curve can be integrated over the time course of the puff to give the
total dose delivered from a puff. In and the axes on the left are scaled differently for the
power, temperature and evaporation rates. and illustrate examples of puffs taken at two
different predetermined puff profiles. In a 35cc puff was pulled over about 3 seconds. In a
70cc puff over about 3 seconds, where the flow rate in is twice that in Illustratively,
comparing to there is a higher mass removal (mass vaporized) for the faster puff of
Different puffs vaporize differing amounts of material. The present disclosure presents that the system is
responsive to varying puff profiles, which do not typically have a uniform flow rate during the puff, and
the duration may vary. This behavior can be further supported by the human study that is discussed
above, where consistent results were obtained, even with variances in puffing attributes representative of
individual or unique human puffs.
Calculation of vaporizable material vaporized – Second Exemplary method
In some embodiments, a vaporizing device, such as device 100, can be calibrated based
on a previous measurement performed using a same or similar device such that an amount of vaporized
material can be determined based upon the performance of the same or similar device. For example, the
device can be calibrated through a function fit method to determine a relationship between total
particulate matter (TPM) release content (mg) and one or more vaporization parameters of aerosolizing
materials from the device by a function fit method.
In some cases, the method for calibration of the device to obtain active material content
from the relationship of total particulate matter (TPM) release content (mg) to vaporization parameters of
aerosolizing materials can comprise setting up an analytical inhalation or smoking machine to its
functioning operating parameters and testing the device under one or more conditions. In some cases,
conditions that can be varied can comprise puff volume and/or flow rate. The conditions (e.g.,
vaporization parameters) can include one or more variable chosen from the group consisting of puff
duration (sec), puff volume (ml), flow rate (ml/sec), power (watts), voltage (volts). In some cases,
exemplary ranges include, but are not limited to 1mL-100mL volume; 0.2s-10s duration; 2-100mL/s; 2.5-
4.2V, respectively.
Total particulate matter (TPM) can be collected from the electronic vaporizer device. In some
cases, the TPM can be collected on a filter pad. The filter pad can be weighed before and after TPM is
collected on the filter such that the weight of the TPM on the filter can be determined. In some cases, the
weight of the filter can be tared. The weight of the material in the device to be vaporized can be recorded
prior to vaporization. In some cases, the weight of the vaporizable material in the device can be measured
and recorded prior to operating the device. The weight of the vaporizable material in the device can be
measured and recorded after one or more puffs on the device. A difference in weight of the vaporizable
material between the initial weight and the weight after one or more puffs can be compared to a weight of
TPM collected on the filter. In some cases, the difference in weight of the vaporizable material between
the initial weight and the weight after one or more puffs and the weight of TPM collected on the filter can
be substantially the same. The TPM collected on the filter can comprise material vaporized from the
vaporizable material in the device during the one or more puffs.
In some cases, an analytical inhalation or smoking device can be a machine configured to
simulate inhalation of a vaporized material from a vaporizing device by a human. While the machine
smoking device vaporizes the formulation in the one or more devices, TPM from the device can be
collected onto one or more filter pads. Each device can have TPM released from the electronic vaporizer
device collected on a different filter pad. For each filter pad the amount of TPM released by a device can
be determined. The amount of TPM released by an individual device relative to the initial weight of
vaporizable material can be calculated. In some cases, this procedure can be repeated with variable
inhalation conditions, for example, with progressively increasing and/or decreasing puff duration (sec) of
the machine inhalation or smoking device. In some cases, the procedure can be repeated with varying
puff volume (ml) of the machine smoking device. The puff volume can vary in the range of 1 mL-100
mL, more preferably, 20-80mL, most preferably 30-60mL. In some cases, the procedure can be repeated
with varying flow rate of the machine smoking device. Flow rate of the machine inhalation or smoking
device can vary in a range of 2-100mL/s, more preferably, 5-50mL/s, most preferably 10-30mL/s. In
some cases, the procedure can be repeated with varying power of the machine inhalation or smoking
device. Power (watts) of the smoking device can vary in the range of 2 watts to 20 watts, more preferably
3 watts to 8 watts. In some cases, the procedure can be repeated with varying voltage of the machine
inhalation or smoking device. Voltage of the device can vary in a range of 2.5-4.2V, more preferably 3.0-
4.2V.
The puff volumes to the corresponding TPM release content (mg) can be tabulated. A
relationship between puff volume and corresponding TPM release content (mg) can be displayed
graphically and/or in a table and can be used to predict, determine, or estimate the amount of vapor
consumed by the user when using a device. For example, Figures 9A and 9B show an exemplary look-up
table and graph that can be used to determine or estimate the amount of vapor inhaled by a user based
upon calibration data previously gathered from an inhalation or smoking machine. The values can be
transmitted to the device, such as the microcontroller within the PCB 240 of device 100, through a
wireless or wired data transfer. The results of the calibration experiment shown in Figures 9A and 9B can
provide information to and permit the user, or other individual, to understand or control the amount of
active material correlated to the TPM level.
Vaporized mass predictor unit
[0132] A vaporizer device, such as devices 10, 100, 100’, may include a vaporized mass predictor (e.g.,
VMP unit), such as within the control unit 10, 110. The VMP 109 may execute the logic described herein
to determine the dose delivered according to any of the methods described herein. In certain
embodiments, the VMP is communicatively coupled to one or more of: a puff sensor (optional), a heater
(e.g., heating element) controller, an alert unit and/or controlling logic. In certain embodiments, a VMP
unit is communicatively coupled to a puff sensor, timer, heater controller and either the alert unit or
controlling logic. In certain embodiments, the VMP includes software (e.g., a software module or control
logic) that runs on the processor. The VMP unit may integrate power readings from the heater controller,
temperature readings from the temperature sensor; and in some cases puff duration or puff frequency
readings from the puff sensor and timer. The VMP unit will then calculate how much vapor has been
vaporized from a vaporizable material.
In some embodiments, the VPM unit of each device can be calibrated separately. In some
embodiments, a VPM calibration can be set based upon a known vaporization material. In some
embodiments, the device can include a user interface that allows the user to input the material being
vaporized, which in turn sets the constants a, b, c for equation 1 and/or the function fit curve or look-up
table.
In some embodiments, the VMP (or another component of the control unit) can calculate the
active material content based upon the TPM. The TPM to active material content can be correlated based
on the composition of the organic materials loaded into the electronic vaporizer device. For example, for
an organic material, that contains a percentage of 20-25% active material, would correlate to a TPM, mg,
containing said percentage of active material. In some cases, it may be reasonable to assume total
conversion (aerosolization) of the active material. For example, for organic material selected from
cannabis extract, where the organic material is a cannabis extract containing 25% cannabidiol (CBD),
then the TPM, mg, correlated to said 25% CBD, means the TPM, mg has the percentage of said active
compound, preferably assuming total conversion (aerosolization) of the active material.
In certain embodiments, the VMP unit is adjustable by the user, and allows the user to preset an
amount of vaporizable material to be vaporized before the user is alerted, or elements of the vaporizer
device are disabled, or the controlling logic is implemented. In certain embodiments, the VMP unit will
then engage an alert unit that alerts a user when a preset amount of a vaporizable material is vaporized. In
certain embodiments, the VMP unit will then disable the vaporizer device when a preset amount of a
vaporizable material is vaporized. In certain embodiments, the VMP is user adjustable, so that the
vaporizer device will vaporize a target amount of material in a single puff.
In certain embodiments, the VMP is user adjustable, so that the vaporizer device will
vaporize a target amount of material in a plurality of puffs. In certain embodiments, the VMP is user
adjustable, so that the vaporizer device will vaporize a target amount of material in a single puff. In some
variations, the VMP is user adjustable so that the device can be disable for a period of time after the target
amount of material has been vaporized. The VMP may be user adjustable so that the device can engage
an alert after a target amount of material has been vaporized. In certain embodiments, the VMP engages
an alert when the amount of vaporizable material in the vaporizer device falls below a preset threshold. In
certain embodiments, the VMP unit is communicatively coupled to a memory unit and stores a plurality
of any of the following measurements: power, temperature, puff duration readings, or any combination
thereof. In certain embodiments, the VMP unit will calculate a cumulative amount of vaporizable material
that is vaporized. If for example a user does not fully vaporize the preset limit in one puff the VMP unit
will keep track of the amount of vaporizable material vaporized over a plurality of puffs. In certain
embodiments, the VMP unit is a software module. In certain embodiments, the VMP unit is a
microprocessor. In certain embodiments, the VMP unit will generate a puff profile that tracks power,
temperature, pressure or a combination thereof over time.
In certain embodiments, the accuracy of the measured TPM vaporized from a VMP unit is at
least ±25% of a predicted value. In certain embodiments, the accuracy of the measured TPM vaporized
from a VMP unit is at least ±20% of a predicted value. In certain embodiments, the accuracy of the
measured TPM vaporized from a VMP unit is at least ±15% of a predicted value. In certain embodiments,
the accuracy of the measured TPM vaporized from a VMP unit is at least ±10% of a predicted value. In
certain embodiments, the accuracy of the measured TPM vaporized from a VMP unit is at least ±5% of a
predicted value. In certain embodiments, the VMP unit is a software component associated with the
processor.
In certain embodiments, the preset amount of vaporized material allowed before the VMP
unit engages an alert is adjustable. In certain embodiments, the preset amount of vaporized material
allowed before the VMP unit engages the controlling logic is adjustable. Adjustment allows a user to be
alerted when a certain amount of vaporizable material has been vaporized, and inhaled by the user, this
allows for an improved user experience by precise control in dosage of a vaporizable material (e.g.,
nicotine, cannabinoid). In certain embodiments, a user can preset an amount of vaporizable material
vaporized in mg of TPM. In certain embodiments, the preset amount of vaporizable material vaporized in
mg of TPM is between about 1 mg and about 1000 mg. In certain embodiments, the preset amount of
vaporizable material vaporized in mg of TPM is between about 1 mg and about 100 mg. In certain
embodiments, the preset amount of vaporizable material vaporized in mg of TPM is between about 10 mg
and about 100 mg. In certain embodiments, the preset amount of vaporizable material vaporized in mg of
TPM is between about 10 mg and about 1000 mg. In certain embodiments, the preset amount of
vaporizable material vaporized in mg of TPM is between about 1 mg and about 50 mg. In certain
embodiments, the preset amount of vaporizable material vaporized in mg of TPM is between about 1 mg
and about 25 mg. In certain embodiments, the preset amount of vaporizable material vaporized in mg of
TPM is less than about 1 mg. In certain embodiments, the preset amount of vaporizable material
vaporized in mg of TPM is about 1 mg. In certain embodiments, the preset amount of vaporizable
material vaporized in mg of TPM is about 2 mg. In certain embodiments, the preset amount of
vaporizable material vaporized in mg of TPM is about 3 mg. In certain embodiments, the preset amount
of vaporizable material vaporized in mg of TPM is about 4 mg. In certain embodiments, the preset
amount of vaporizable material vaporized in mg of TPM is about 5 mg. In certain embodiments, the
preset amount of vaporizable material vaporized in mg of TPM is about 6 mg. In certain embodiments,
the preset amount of vaporizable material vaporized in mg of TPM is about 7 mg. In certain
embodiments, the preset amount of vaporizable material vaporized in mg of TPM is about 8 mg. In
certain embodiments, the preset amount of vaporizable material vaporized in mg of TPM is about 9 mg.
In certain embodiments, the preset amount of vaporizable material vaporized in mg of TPM is about 10
mg. In certain embodiments, the preset amount of vaporizable material vaporized in mg of TPM is about
mg. In certain embodiments, the preset amount of vaporizable material vaporized in mg of TPM is
about 30 mg. In certain embodiments, the preset amount of vaporizable material vaporized in mg of TPM
is about 40 mg. In certain embodiments, the preset amount of vaporizable material vaporized in mg of
TPM is about 50 mg. In certain embodiments, the preset amount of vaporizable material vaporized in mg
of TPM is about 60 mg. In certain embodiments, the preset amount of vaporizable material vaporized in
mg of TPM is about 70 mg. In certain embodiments, the preset amount of vaporizable material vaporized
in mg of TPM is about 80 mg. In certain embodiments, the preset amount of vaporizable material
vaporized in mg of TPM is about 90 mg. In certain embodiments, the preset amount of vaporizable
material vaporized in mg of TPM is about 100 mg.
In certain embodiments, a user can preset an amount of vaporizable material vaporized in mg
of an active ingredient (e.g., nicotine, cannabinoid, THC). In certain embodiments, the preset amount of
vaporizable material vaporized in mg of an active ingredient is between about 1 mg and about 1000 mg.
In certain embodiments, the preset amount of vaporizable material vaporized in mg of an active
ingredient is between about 1 mg and about 100 mg. In certain embodiments, the preset amount of
vaporizable material vaporized in mg of an active ingredient is about 0.05 mg. In certain embodiments,
the preset amount of vaporizable material vaporized in mg of an active ingredient is about 0.1 mg. In
certain embodiments, the preset amount of vaporizable material vaporized in mg of an active ingredient is
about 0.2 mg. In certain embodiments, the preset amount of vaporizable material vaporized in mg of an
active ingredient is about 0.3 mg. In certain embodiments, the preset amount of vaporizable material
vaporized in mg of an active ingredient is about 0.4 mg. In certain embodiments, the preset amount of
vaporizable material vaporized in mg of an active ingredient is about 0.5 mg. In certain embodiments, the
preset amount of vaporizable material vaporized in mg of an active ingredient is about 0.6 mg. In certain
embodiments, the amount of vaporizable material vaporized in mg of an active ingredient is about 0.7 mg.
In certain embodiments, the preset amount of vaporizable material vaporized in mg of an active
ingredient is about 0.8 mg. In certain embodiments, the preset amount of vaporizable material vaporized
in mg of an active ingredient is about 0.9 mg. In certain embodiments, the preset amount of vaporizable
material vaporized in mg of an active ingredient is about 1 mg. In certain embodiments, the preset amount
of vaporizable material vaporized in mg of an active ingredient is about 2 mg. In certain embodiments,
the preset amount of vaporizable material vaporized in mg of an active ingredient is about 3 mg. In
certain embodiments, the preset amount of vaporizable material vaporized in mg of an active ingredient is
about 4 mg. In certain embodiments, the preset amount of vaporizable material vaporized in mg of an
active ingredient is about 5 mg. In certain embodiments, the preset amount of vaporizable material
vaporized in mg of an active ingredient is about 6 mg. In certain embodiments, the preset amount of
vaporizable material vaporized in mg of an active ingredient is about 7 mg. In certain embodiments, the
preset amount of vaporizable material vaporized in mg of an active ingredient is about 8 mg. In certain
embodiments, the preset amount of vaporizable material vaporized in mg of an active ingredient is about
9 mg. In certain embodiments, the preset amount of vaporizable material vaporized in mg of an active
ingredient is about 10 mg. In certain embodiments, the preset amount of vaporizable material vaporized in
mg of an active ingredient is about 10 mg. In certain embodiments, the preset amount of vaporizable
material vaporized in mg of an active ingredient is about 20 mg. In certain embodiments, the preset
amount of vaporizable material vaporized in mg of an active ingredient is about 30 mg. In certain
embodiments, the preset amount of vaporizable material vaporized in mg of an active ingredient is about
40 mg. In certain embodiments, the preset amount of vaporizable material vaporized in mg of an active
ingredient is about 50 mg. In certain embodiments, the preset amount of vaporizable material vaporized in
mg of an active ingredient is about 60 mg. In certain embodiments, the preset amount of vaporizable
material vaporized in mg of an active ingredient is about 70 mg. In certain embodiments, the preset
amount of vaporizable material vaporized in mg of an active ingredient is about 80 mg. In certain
embodiments, the preset amount of vaporizable material vaporized in mg of an active ingredient is about
90 mg. In certain embodiments, the preset amount of vaporizable material vaporized in mg of an active
ingredient is about 100 mg.
In a certain embodiment, the VMP unit is user adjustable using a button. In a certain
embodiment, the VMP unit is user adjustable using a dial. In a certain embodiment, the VMP unit is user
adjustable using a capacitive interface. In a certain embodiment, the VMP unit is user adjustable using a
wireless connection. In a certain embodiment, the VMP unit is user adjustable using voice
communication.
In a certain embodiment, the type of vaporizable material is adjustable. In a certain
embodiment the type of vaporizable material that is adjustable is nicotine. In a certain embodiment, the
type of vaporizable material that is adjustable is a Cannabis. In a certain embodiment, the type of
vaporizable material that is adjustable is a cannabinoid. In a certain embodiment, the type of vaporizable
material that is adjustable is a medicinal compound. In a certain embodiment, the type of vaporizable
material that is adjustable is a botanical. In a certain embodiment, the type of vaporizable material that is
adjustable is a nutraceutical. In some embodiments, the type of material that is adjustable is formulation
specific (e.g., a percent compound dissolved in a specific solvent).
In a certain embodiment, the VMP unit integrates readings from the puff sensor, temperature
sensor, heating element controller and timer to create profiles of the readings. A power profile is the
change in power delivery over time. A temperature profile is the change in temperature over time. In a
certain embodiment, the profile is measured from the initiation of the puff, as measured by the puff sensor
to the cessation of the puff, as measured by the puff sensor. In a certain embodiment, the VMP unit stores
a plurality of profiles in a memory unit.
[0143] In real time, the VMP unit can take a device’s data and use it to calculate cumulative TPM in
mg. For example, when the TPM reaches 40 mg, the human subject can be prompted to stop puffing, or
the heating element can be adjusted or turned off. The constants can be modified to account for different
pods and different liquids.
In certain embodiments, the electronic vaporizer device utilizing the method of determining
the amount of vapor delivered to the user described herein, such as device 100, comprises an alert unit. In
certain embodiments, the alert unit alerts a user when a preset amount of vaporizable material is
vaporized. In certain embodiments, the alert unit notifies the user when the vaporizer device is low on
vaporizable material. In certain embodiments, the alert unit alerts the user when the amount of
vaporizable material in the vaporizer device falls below 10%. In certain embodiments, the alert unit alerts
the user when the amount of vaporizable material in the vaporizer device falls below 5%. In certain
embodiments, the alert unit is a light emitting diode (LED). In certain embodiments, the alert unit is an
organic light emitting diode (OLED). In certain embodiments, the LED or OLED is communicatively
coupled to the VMP unit. In certain embodiments, the LED or OLED illuminates when the amount of
vapor delivered to a user meets or exceeds a preset amount. In certain embodiments, the LED or OLED
flashes when the amount of vapor delivered to a user meets or exceeds a preset amount. In certain
embodiments, the LED or OLED emits light in different color spectrums. In certain embodiments, the
LED or OLED emits red light. In certain embodiments, the LED or OLED emits orange light. In certain
embodiments, the LED or OLED emits yellow light. In certain embodiments, the LED or OLED emits
green light. In certain embodiments, the LED or OLED emits blue light. In certain embodiments, the LED
or OLED emits purple light. In certain embodiments, the LED or OLED emits more than one color light,
the more than one color can be any combination of the above mentioned colors. In certain embodiments,
the LED or OLED emits flashing light in any of the aforementioned colors.
[0145] In certain embodiments, the electronic vaporizer device utilizing the method comprises an
alert unit. In certain embodiments, the alert unit is a piezoelectric speaker. In certain embodiments, the
piezoelectric speaker is communicatively coupled to the VMP unit. In certain embodiments, the
piezoelectric speaker emits sound when the amount of vapor delivered to a user meets or exceeds a preset
amount. In certain embodiments, the sound is a chime, bell, tone, multitoned sound, song or the like.
[0146] In certain embodiments, the electronic vaporizer device utilizing the method comprises an
alert unit. In certain embodiments, the alert unit is a vibration motor, which provides tactile feedback to
the user. In certain embodiments, the vibration motor is communicatively coupled to the VMP unit. In
certain embodiments, the vibration motor activates when the amount of vapor delivered to a user meets or
exceeds a preset amount.
[0147] In certain embodiments, the electronic vaporizer device utilizing the method comprises more
than one alert unit. In certain embodiments, the more than one alert unit is an LED or OLED, a
piezoelectric speaker, vibration motor or any combination thereof.
The alert unit (or simply the alert) may be configured as a dose output, as shown
schematically in The dose output may be a visual output (e.g., LCD/LED, etc.) and/or a wireless
output to a display device (e.g., a smartphone or other wearable device running an application that
communicates with the vaporization device, typically wirelessly). The application and therefore the
hardware (e.g., wearable device, remote server, etc.) running the application may store, analyze, transmit,
display and/or aggregate the dose information (and/or the raw timing, temperature and power, etc., data).
In certain embodiments, the electronic vaporizer device utilizing the method of determining
the amount of vapor delivered to the user described herein, such as device 100, includes a controlling
logic or a disabling unit. In certain embodiments, the controlling logic is a software module. In certain
embodiments, the controlling logic is a firmware module. In certain embodiments, the controlling logic is
a hardware element. In certain embodiments, the controlling logic will prompt the VMP unit to relay
instructions to the heating element controller to allow a user to vaporize a target amount of TPM in a
single puff. In certain embodiments, the controlling logic will prompt the VMP unit to relay instructions
to the heating element controller to allow a user to vaporize a target amount of TPM in a plurality of
puffs. In certain embodiments, the controlling logic is communicatively coupled to VMP unit. In certain
embodiments, the controlling logic inactivates the heating element. In certain embodiments, the
controlling logic modifies the amount of power delivered to the heating element. In certain embodiments,
the controlling logic turns the electronic vaporizer device off. In certain embodiments, the user can
override the controlling logic to restore proper operation of the vaporizer device.
In any of the apparatuses described herein, the electronic vaporizer device utilizing the
method of determining the amount of vapor produced (and therefore delivered to a user), such as devices
, 100. 100’, may include a memory. In certain embodiments, the memory (e.g., memory unit) is
hardware that is communicatively coupled to the VMP. In certain embodiments, the memory is internal to
the electronic vaporizer device. In certain embodiments, the memory is external to the electronic
vaporizer device. In certain embodiments, the memory is configured to store a plurality of any of
temperature, power, pressure, time, puff duration, puff frequency measurements and combinations
thereof. In certain embodiments, the memory unit is a solid state memory. In certain embodiments, the
memory unit is a hard disk.
In any of the electronic vaporizer device described herein, such as devices 10, 100. 100’, the
apparatus may include a processor. In certain embodiments, the processor may include software,
firmware and/or hardware that executes the controlling logic of the device. In certain embodiments, the
processor is communicatively coupled to the VMP unit. In certain embodiments, the VMP unit and the
processor are the same element. In certain embodiments, the processor is communicatively coupled to the
user interface. In certain embodiments, the processor is communicatively coupled to the memory unit.
As described above, the electronic vaporizer devices described herein may include a power
source, such as power source 230. In certain embodiments, the power source is removable. In certain
embodiments, the power source is a battery. In certain embodiments, the power source is a rechargeable
battery. In certain embodiments, the rechargeable battery is a lithium ion battery. In certain embodiments,
the rechargeable battery is compatible with a USB charging cable. In certain embodiments, the electronic
vaporizer device with a rechargeable battery is compatible with a micro USB charging cable. In certain
embodiments, the rechargeable battery is compatible with a charging cradle. A charging cradle is any
physical device capable of supporting the electronic vaporizer device while charging; the cradle can either
be integral to the electronic vaporizer device, or separate from the electronic vaporizer device. In certain
embodiments, the charging cradle has charging contacts, configured to mate to contacts on the electronic
vaporizer device. In certain embodiments, the charging cradle charges the electronic vaporizer device
using induction technology. In certain embodiments, the charging cradle is an induction charging mat.
The power source may be configured to deliver power to the heating element, and may be
regulated by the heater controller. The heater controller may therefore receive charge/power level input
from the power source and may adjust its output accordingly. In certain embodiments, the power source
is configured to deliver an adjustable amount of power. In certain embodiments, the amount of power is
adjustable by the user. In certain embodiments, the amount of power is adjusted by the VMP unit. As
mentioned, the power source may be communicatively coupled to the heater controller. In certain
embodiments, the power source is configured to deliver an adjustable amount of power and is controlled
by the VMP unit. In certain embodiments, the power source delivers between 1 and 100 watts of power.
In certain embodiments, the power source delivers between 1 and 50 watts of power. In certain
embodiments, the power source delivers between 1 and 20 watts of power. In certain embodiments, the
power source delivers between 1 and 10 watts of power. In certain embodiments, the power source
delivers between 1 and 8 watts of power. In certain embodiments, the power source delivers between 2
and 10 watts of power. In certain embodiments, the power source delivers between 10 and 100 watts of
power. In certain embodiments, the power source delivers between 10 and 50 watts of power. In certain
embodiments, the power source delivers between 10 and 20 watts of power. In certain embodiments, the
power source delivers about 4 watts of power. In certain embodiments, the power source delivers about
4.5 watts of power. In certain embodiments, the power source delivers about 5 watts of power. In certain
embodiments, the power source delivers about 5.5 watts of power. In certain embodiments, the power
source delivers about 6 watts of power. In certain embodiments, the power source delivers about 6.5 watts
of power. In certain embodiments, the power source delivers about 7 watts of power. In certain
embodiments, the power source delivers about 7.5 watts of power. In certain embodiments, the power
source delivers about 8 watts of power. In certain embodiments, the power source delivers about 8.5 watts
of power. In certain embodiments, the power source delivers about 9 watts of power. In certain
embodiments, the power source delivers about 10 watts of power. In certain embodiments, the power
source delivers about 20 watts of power. In certain embodiments, the power source delivers about 30
watts of power. In certain embodiments, the power source delivers about 40 watts of power. In certain
embodiments, the power source delivers about 10 watts of power. In certain embodiments, the power
source delivers about 50 watts of power. In certain embodiments, the power source delivers about 60
watts of power. In certain embodiments, the power source delivers about 70 watts of power. In certain
embodiments, the power source delivers about 80 watts of power. In certain embodiments, the power
source delivers about 90 watts of power. In certain embodiments, the power source delivers about 100
watts of power. The power applied may alternatively or additionally (and equivalently) be expressed in
joules. For example, in certain embodiments, the power source delivers between 1 and 1000 joules to the
heater. In certain embodiments, the power source delivers between 1 and 500 joules to the heater. In
certain embodiments, the power source delivers between 1 and 100 joules to the heater. In certain
embodiments, the power source delivers between 1 and 50 joules to the heater. In certain embodiments,
the power source delivers between 1 and 25 joules to the heater. In certain embodiments, the power
source delivers between 5 and 25 joules to the heater. In certain embodiments, the power source delivers
between 1 and 20 joules to the heater. In certain embodiments, the power source delivers between 5 and
joules to the heater. In certain embodiments, the power source delivers between 10 and 500 joules to
the heater. In certain embodiments, the power source delivers between 10 and 100 joules to the heater. In
certain embodiments, the power source delivers between 10 and 50 joules to the heater. In certain
embodiments, the power source delivers between 10 and 20 joules to the heater.
As described above, any of the vaporizer apparatuses described herein may include a heater
(heating element). In certain embodiments, the heater is a resistive heating element. In certain
embodiments, the heating element forms a coil. In certain embodiments, the coil is wrapped around a
wick. In certain embodiments, the wick is in contact with a vaporizable material. In certain embodiments,
the wick projects into the vaporizable material.
In certain embodiments, the heating element heats the vaporizable material to between 40 and
1000 degrees Celsius. In certain embodiments, the heating element heats the vaporizable material to
between 100 and 900 degrees Celsius. In certain embodiments, the heating element heats the vaporizable
material to between 100 and 800 degrees Celsius. In certain embodiments, the heating element heats the
vaporizable material to between 100 and 700 degrees Celsius. In certain embodiments, the heating
element heats the vaporizable material to between 100 and 600 degrees Celsius. In certain embodiments,
the heating element heats the vaporizable material to between 100 and 500 degrees Celsius. In certain
embodiments, the heating element heats the vaporizable material to between 100 and 400 degrees Celsius.
In certain embodiments, the heating element heats the vaporizable material to between 100 and 300
degrees Celsius. In certain embodiments, the heating element heats the vaporizable material to between
180 and 250 degrees Celsius. In certain embodiments, the heating element heats the vaporizable material
to between 100 degrees Celsius and 200 degrees Celsius. In certain embodiments, the heating element
heats the vaporizable material to between 125 degrees Celsius and 175 degrees Celsius. In certain
embodiments, the heating element heats the vaporizable material to about 150 degrees Celsius. In certain
embodiments, the heating element heats the vaporizable material to between 200 and 300 degrees Celsius.
In certain embodiments, the heating element heats the vaporizable material to between 225 and 275
degrees Celsius. In certain embodiments, the heating element heats the vaporizable material to about 250
degrees Celsius. In certain embodiments, the heating element heats the vaporizable material to between
300 and 400 degrees Celsius. In certain embodiments, the heating element heats the vaporizable material
to between 325 and 375 degrees Celsius. In certain embodiments, the heating element heats the
vaporizable material to about 350 degrees Celsius. In certain embodiments, the heating element heats the
vaporizable material to between 400 and 500 degrees Celsius. In certain embodiments, the heating
element heats the vaporizable material to between 500 and 600 degrees Celsius. In certain embodiments,
the heating element heats the vaporizable material to between 600 and 700 degrees Celsius. In certain
embodiments, the heating element heats the vaporizable material to between 700 and 800 degrees Celsius.
In certain embodiments, the heating element heats the vaporizable material to between 800 and 900
degrees Celsius. In certain embodiments, the heating element heats the vaporizable material to between
900 and 1000 degrees Celsius. In certain embodiments, when the vaporizable material is Cannabis or a
cannabinoid, the heating element heats the vaporizable material to between 300 and 400 degrees Celsius.
In certain embodiments, when the vaporizable material is Cannabis or a cannabinoid, the heating element
heats the vaporizable material to between 325 and 375 degrees Celsius. In certain embodiments, when the
vaporizable material is Cannabis or a cannabinoid, the heating element heats the vaporizable material to
about 350 degrees Celsius. In certain embodiments, when the vaporizable material is nicotine or a
nicotine derivative, the heating element heats the vaporizable material to between 200 and 300 degrees
Celsius. In certain embodiments, when the vaporizable material is nicotine or a nicotine derivative, the
heating element heats the vaporizable material to between 225 and 275 degrees Celsius. In certain
embodiments, when the vaporizable material is nicotine or a nicotine derivative, the heating element heats
the vaporizable material to about 250 degrees Celsius.
In one embodiment, the heating element is housed within a vaporization chamber surrounded
by vaporization chamber walls. The vaporization chamber is also referred to as the atomizer. In some
embodiments, the vaporization chamber walls can be constructed of any material capable of withstanding
repeated heating to the operating temperature of the vaporizer device. In some embodiments, the
vaporization chamber walls can be constructed of any material capable of withstanding repeated heating
to 300 degrees Celsius. The vaporization chamber possesses an air inlet, to allow the entrance of air to the
atomizer, and an air outlet, to allow vapor to escape to the user. Vaporizable material is introduced to the
atomizer by a wick, which is in fluid communication with a vaporizable material. The vaporizable
material can be stored in a tank integral to the electronic vaporizer device or in a removable tank (pod),
configured to be detached from the vaporizer device after it is depleted. In an alternative embodiment, the
heater element is in an oven configuration, wherein the heating element surrounds a chamber with
stainless steel walls, and heats a vaporizable material, placed within the chamber, by conduction. In an
oven configuration, the inside of the oven can be exposed to the outside by removal of an oven lid, which
allows loading of a vaporizable material. The oven can further contain an outlet that allows vapor to
escape to the user.
In any of the vaporizer devices described herein, the apparatus may include a heater
controller (e.g., a heating element controller). In certain embodiments, the heater controller operates the
heating element. In certain embodiments, the heater controller switches the heater on and off, and/or
switches the heater on and off in a rapid “pulsed” fashion. In certain embodiments, the heater controller is
configured to detect and/or control the power delivered from the power source. In certain embodiments,
the heater controller is configured to detect and/or control the voltage delivered from the power source. In
certain embodiments, the heater controller is configured to detect and/or control the current delivered
from the power source. In certain embodiments, the heater controller is configured to detect and/or
control the power, voltage and/or current delivered, or any combination thereof from the power source. In
certain embodiments, the heater controller is connected in series with the power source and the heater. In
certain embodiments, the heater controller is connected to the power source in parallel with the heater. In
certain embodiments, the heater controller is configured to detect and/or control the power delivered from
the power source in Watts. In certain embodiments, the heater controller is configured to detect and/or
control the voltage delivered from the power source in Volts. In certain embodiments, the heater
controller is configured to detect and/or control the current delivered from the power source in Amps. In
certain embodiments, the heater controller is communicatively coupled to the VMP unit.
In certain embodiments, the heater controller is configured to regulate the operation of the
heater. In certain embodiments, the heater controller is configured to regulate the temperature of the
heater. In certain embodiments, the heater controller is configured to regulate the voltage delivered to the
heater by the power source. In certain embodiments, the heater controller is configured to regulate the
current delivered to the heating element by the power source. In certain embodiments, the heater
controller is configured to regulate the wattage delivered to the heater by the power source. In certain
embodiments, the heater controller is configured to regulate the temperature of the heater by regulating
power delivered from the power source. In certain elements, the heating element controller is
communicatively coupled to the processor. In certain embodiments, the heater controller is configured to
receive instructions from the processor.
As discussed above, and described in U.S. patent application no. 14/581,666, the heater
controller may use control logic (e.g., a PID loop) including one or more inputs such as the temperature,
e.g., determined using the coefficient of resistance or TCR of the heater. Thus, in determining the dose
(e.g., partial doses of a puff), the apparatus may advantageously use just electrical values (resistance and
power values) from the controller, once calibrated with the appropriate constants (which may be
analytically or theoretically determined as mentioned above, or may be assumed/ignored).
Cartridge
As described above, in some embodiments, the electronic vaporizer device utilizing the
method of determining the amount of vapor delivered to the user described herein, such as device 100,
includes a separate detachable pod configured to hold a vaporizable material. In certain embodiments, the
pod is any receptacle or tank configured to hold a vaporizable material. In certain embodiments, the pod
is removable. In certain embodiments, the pod is replaceable. In certain embodiments, the pod and the
electronic vaporizer device form a single unit after the pod is attached to the electronic vaporizer device.
In certain embodiments, the pod further comprises a mouthpiece. In certain embodiments, the electronic
vaporizer device utilizing the method does not comprise a separate pod configured to hold a vaporizable
material, and vaporizable material is stored in the electronic vaporizer device. In certain embodiments, the
separate pod contains a vaporization chamber. In certain embodiments, the pod holds between.1 and 10
ml of a liquid, viscous liquid or wax. In certain embodiments, the pod holds between 1 and 10 ml of a
liquid, viscous liquid or wax. In certain embodiments, the pod holds between.1 and 2 ml of a liquid,
viscous liquid or wax. In certain embodiments, the pod holds between.5 and 1.5 ml of a liquid, viscous
liquid or wax.
In some embodiments, the cartridge can be filled with non-hydroscopic solvents and/or be
substantially airtight so as to avoid absorption of water in the cartridge, thereby ensuring a predictable and
accurate dose calculation.
Temperature sensor
As described above, any of the vaporizer apparatuses described herein, such as devices 10,
100, 100’ in FIGS. 1A-1C, can include one or more temperature sensors, such as temperature sensor 250.
In certain embodiments, the temperature sensor is configured to measure the temperature of the heating
element. The temperature sensor may include software and hardware for measuring the resistance that
may be integral with (or separate from) any of the controller and/or processors described herein. In
certain embodiments, the temperature sensor is configured to measure the temperature of a vaporization
chamber housing the heating element. In certain embodiments, the temperature sensor is configured to
measure the temperature of an oven chamber heated by the heating element. In certain embodiments, the
temperature sensor measures heat in degrees Celsius. In certain embodiments, the temperature sensor
measures heat in degrees Fahrenheit. In certain embodiments, the temperature sensor measures heat in
degrees Kelvin. In certain embodiments, the temperature sensor is a thermocouple. In certain
embodiments, the temperature sensor is a thermistor. In certain embodiments, the temperature sensor is an
infrared temperature sensor. In certain embodiments, the temperature sensor is a relative resistance
gradient measurement system. In certain embodiments, the temperature sensor is the heater coil used to
heat the vaporizable material.
[0163] In certain embodiments, the temperature sensor measures a temperature to an accuracy of
±0.1 degrees Celsius. In certain embodiments, the temperature sensor measures a temperature to an
accuracy of ±0.2 degrees Celsius. In certain embodiments, the temperature sensor measures a temperature
to an accuracy of ±0.3 degrees Celsius. In certain embodiments, the temperature sensor measures a
temperature to an accuracy of ±0.4 degrees Celsius. In certain embodiments, the temperature sensor
measures a temperature to an accuracy of ±0.5 degrees Celsius. It should be noted that the accuracy of the
measured temperature may be as poor as +/- 25°C (e.g., less than 25°C, 24°C, 23°C, 22°C, 21°C, 20°C,
19°C, 18°C, 17°C, 16°C, 15°C, 14°C, 13°C, 12°C, 11°C, 10°C, 9°C, 8°C, 7°C, 6°C, 5°C, 4°C, 3°C, 2°C,
1°C, etc.). In certain embodiments, the temperature sensor measures temperature indirectly by measuring
the resistance of the heating element. In certain embodiments, resistance is measured in Ohms. In certain,
embodiments, the temperature sensor is capable of measuring a temperature profile, which is a change in
temperature over time.
Puff sensor
As described above, the vaporizer apparatuses described herein may optionally include a puff
sensor. In certain embodiments, the puff sensor measures the initiation of the users puff. In certain
embodiments, the puff sensor measures the cessation of the users puff. In certain embodiments, the puff
sensor measures the duration of the users puff. In certain embodiments, the puff sensor measures the
velocity and amount of air traveling through the electronic vaporizer device. In certain embodiments, the
puff sensor is a button that is pressed upon initiation of a user’s puff. In certain embodiments, the puff
sensor is a pressure sensor. In certain embodiments, the pressure sensor is a Venturi meter. In certain
embodiments, the pressure sensor is an orifice plate. In certain embodiments, the pressure sensor is a Dall
tube. In certain embodiments, the pressure sensor is a pitot-static tube. In certain embodiments, the
pressure sensor is a multi-hole pressure probe. In certain embodiments, the pressure sensor is a cone
meter. In certain embodiments, the puff sensor comprises a button that is pressed by the user to initiate a
puff. In certain embodiments, the puff sensor is a flow meter. In certain embodiments, the flow meter is a
turbine flow meter. In certain embodiments, the puff sensor is communicatively coupled to the VMP unit.
In certain embodiments, the puff sensor is configured to measure a puff initiated by the user. In certain
embodiments, the puff sensor is configured to measure a puff initiated by an analytical smoking machine.
Timer
In certain embodiments, the electronic vaporizer device utilizing the method of determining
the amount of vapor delivered to the user described herein, such as device 100, includes a timer. In a
certain embodiment, the timer is communicatively coupled to the temperature sensor. In certain
embodiments, the timer is communicatively coupled to the puff sensor. In certain embodiments, the timer
measures a puff duration. In certain embodiments, the timer measures a puff frequency. In certain
embodiments, the timer is communicatively coupled to the VMP unit. In certain embodiments, the timer
is communicatively coupled to both the puff sensor and the VMP unit. In some instances, a puff duration
can range from about 0.1 seconds to about 10 seconds. In some instances, a puff duration can range from
about 1 second to about 5 seconds. In some instances, a puff duration can range from about 1 second to
about 4 seconds. In some instances, a puff duration can range from about 1 second to about 3 seconds. In
some instances, a puff duration can range from about 1 second to about 2 seconds. In certain
embodiments, the accuracy of a measurement of the puff duration is within about ± 0.05 seconds. In
certain embodiments, the accuracy of a measurement of the puff duration is within about ± 0.1 seconds.
In certain embodiments, the accuracy of a measurement of the puff duration is within about ± 0.2
seconds. In certain embodiments, the accuracy of a measurement of the puff duration is within about ±
0.3 seconds. In certain embodiments, the accuracy of a measurement of the puff duration is within about
± 0.4 seconds. In certain embodiments, the accuracy of a measurement of the puff duration is within
about ± 0.5 seconds.
In some variations, the heated reservoir may be heated. Referring to in certain
embodiments, the electronic vaporizer device utilizing the method of determining the amount of vapor
delivered to the user described herein, such as device 100, includes a heat block reservoir (or heat
reservoir or heat block).
[0167] Heating the reservoir may allow for a more controlled initial state, which may enhance the
predictability of the dose estimation. This is illustrated in FIG 8. In some variations, and particularly
those illustrated above, heating the reservoir may be unnecessary as sufficiently accurate dose (vapor)
estimations may be determined. FIGs 9A and 9B conceptual relate to a model which may benefit from
using a heated reservoir. Alternatively, just the portion of the vaporizable material feeding into the
vaporizing region (e.g., wick) may be heated.
Smoking vaporizable organic formulations that may be thick (non-flowing) or non-liquid
with electronic vaporizer devices can pose a challenge. However, there remains an unmet need of
vaporizing organic formulations that are otherwise thick (non-flowing) liquids or non-liquids, that
include, but are not limited to, for example, Cannabis extracts. In certain embodiments, the heat reservoir
is distinct form the heating element. In certain embodiments, the heat reservoir is fluidly coupled to the
heater element. In certain embodiments, the heat reservoir is constructed of stainless steel. In certain
embodiments, the heat reservoir is constructed of high temperature plastic. In certain embodiments, the
heat reservoir preheats a viscous, semi-solid or solid composition, before vaporization with the heating
element. In certain embodiments, the heat reservoir preheats a vaporizable material to between 40 degrees
Celsius and 100 degrees Celsius. In certain embodiments, the heat reservoir preheats a vaporizable
material to between 40 degrees Celsius and 80 degrees Celsius. In certain embodiments, the heat reservoir
preheats a vaporizable material to between 40 degrees Celsius and 60 degrees Celsius. In certain
embodiments, the heat reservoir preheats a vaporizable material to about 50 degrees Celsius. In certain
embodiments, the heat reservoir preheats a vaporizable material to between 50 degrees Celsius and 100
degrees Celsius. In certain embodiments, the heat reservoir preheats a vaporizable material to between 60
degrees Celsius and 100 degrees Celsius. In certain embodiments, the heat reservoir preheats a
vaporizable material to between 70 degrees Celsius and 100 degrees Celsius. In certain embodiments, the
heat reservoir preheats a vaporizable material to between 80 degrees Celsius and 100 degrees Celsius. In
certain embodiments, the heat reservoir preheats a vaporizable material to between 90 degrees Celsius
and 100 degrees Celsius. In certain embodiments, the heat block is configured to warm material that
exhibits a viscosity between 50 and 1000 Centipoise. In certain embodiments, the heat block is configured
to warm material that exhibits a viscosity between 1,000 and 5,000 Centipoise. In certain embodiments,
the heat block is configured to warm material that exhibits a viscosity between 5,000 and 50,000
Centipoise. In certain embodiments, the heat block is configured to warm material that exhibits a
viscosity above 5,000 Centipoise (or above 10,000 Centipoise, above 20,000 Centipoise, above 30,000
Centipoise, above 40,000 Centipoise, etc.).
An analytical vaporizer device smoking machine was employed in this example, which is
similar to machines known in the art. An electronic vaporizer device including a heat block reservoir for
thick (non-flowing) liquids or non-liquids, was compared to an electronic vaporizer device without a heat
reservoir. The heat reservoir preheats the thick (non-flowing) liquids or non-liquids. When the thick (non-
flowing) liquids or non-liquids are preheated prior to vaporization the effect of uneven heating is reduced
during vaporization. shows graphical data depicting the number of puffs relative to the TPM
release content (mg) of a non-heated reservoir of an electronic vaporizer device compared with the
number of puffs relative to the TPM release content (mg) of a heat reservoir of an electronic vaporizer
device, where the latter’s reservoir was pre-heated to a temperature of 40-60°C. Where the reservoir was
pre-heated to a temperature of 40-60°C, a more or less consistent amount of TPM (mg) was generated
from a viscous or thick non-flowing organic formulation; while the electronic vaporizer device without a
heat block reservoir, vaporized inconsistent amounts of TPM (mg). An inconsistency of the TPM
produced by the unheated reservoir can be a result of uneven heating of the vaporizable material.
Vaporizable material
As described above, the vaporizer apparatuses described herein may be used with (and may
include or be configured specifically for) any appropriate vaporizable material. In certain embodiments,
the vaporizable material is an organic material. In certain embodiments, vaporizable material is a liquid,
viscous liquid, wax or loose-leaf material. In certain embodiments, the vaporizable material is a tobacco-
based material. In certain embodiments, the vaporizable material is a Cannabis based material. In certain
embodiments, the vaporizable material is a botanical. In certain embodiments, the vaporizable material is
nicotine, a nicotine derivative or a nicotine salt. In certain embodiments, the vaporizable material is a
nutraceutical. In certain embodiments, the vaporizable material contains a cannabinoid. In certain
embodiments, the vaporizable material is a medicinal compound.
[0171] In certain embodiments, the vaporizable material exhibits a viscosity between 1 and 50
Centipoise. In certain embodiments, the vaporizable material exhibits a viscosity between 50 and 1,000
Centipoise. In certain embodiments, the vaporizable material exhibits a viscosity between 1,000 and
,000 Centipoise. In certain embodiments, the vaporizable material exhibits a viscosity between 5,000
and 10,000 Centipoise. In certain embodiments, the vaporizable material exhibits a viscosity above
10,000 Centipoise.
In certain embodiments, the vaporizable material contains nicotine. In certain embodiments,
the vaporizable material contains a nicotine derivative. In certain embodiments, the nicotine derivative is
an acid salt of nicotine. In certain embodiments, the acid salt of nicotine comprises an organic acid. In
certain embodiments, the acid salt of nicotine does not comprise an inorganic acid. In certain
embodiments, the nicotine derivative is cotinine, In certain embodiments, the nicotine derivative is
norcotinine. In certain embodiments, the nicotine derivative is nornicotine. In certain embodiments, the
nicotine derivative is nicotine N-oxide. In certain embodiments, the nicotine derivative is cotinine N-
oxide. In certain embodiments, the nicotine derivative is 3-hydroxycotinine. In certain embodiments, the
nicotine derivative is 5-hydroxycotinine.
[0173] In certain embodiments, the vaporizable material is a formulation of nicotine, nicotine
derivatives, or a nicotine salt. In some formulations the concentration of nicotine or derivatives thereof in
the formulation is about 1% (w/w) to about 25% (w/w). In some formulations the concentration of
nicotine or derivatives thereof; in the formulation is about 1% (w/w) to about 20% (w/w). In some
formulations the concentration of nicotine in the formulation is about 1% (w/w) to about 18% (w/w). In
some embodiments, the concentration of nicotine in the formulation is about 1% (w/w) to about 15%
(w/w). In some embodiments, the concentration of nicotine in the formulation is about 1% (w/w) to about
% (w/w). In some embodiments, the concentration of nicotine in the formulation is about 1% (w/w) to
about 8% (w/w). In some embodiments, the concentration of nicotine in the formulation is about 2%
(w/w) to about 10% (w/w). In some formulations the concentration of nicotine in the formulation is about
4% (w/w) to about 12% (w/w). In some formulations the concentration of nicotine in the formulation is
about 4% (w/w). In some embodiments, the concentration of nicotine in the formulation is about 2%
(w/w).
Nicotine salt formulations are formed by the addition of a suitable acid to nicotine or a
derivative thereof, including organic or inorganic acids. In some formulations provided herein, suitable
organic acids are carboxylic acids. Examples of organic carboxylic acids disclosed herein are
monocarboxylic acids, dicarboxylic acids (organic acid containing two carboxylic acid groups),
carboxylic acids containing an aromatic group such as benzoic acids, hydroxycarboxylic acids,
heterocyclic carboxylic acids, terpenoid acids, sugar acids; such as the pectic acids, amino acids,
cycloaliphatic acids, aliphatic carboxylic acids, keto carboxylic acids, and the like. In some formulations
provided herein, the organic acids used herein are monocarboxylic acids. In some formulations provided
herein the organic carboxylic acid is benzoic, levulinic, acetic, lactic, citric, sorbic, lauric, salicylic,
pyruvic or a combination thereof. In some formulations provided herein the organic carboxylic acid is not
levulinic. Nicotine salts are formed from the addition of a suitable acid to nicotine. In some formulations
provided herein, the stoichiometric ratios of the nicotine to acid (nicotine: acid) are 1:1, 1:2, 1:3, 1:4, 2:3,
2:5, 2:7, 3:4, 3:5, 3:7, 3:8, 3:10, 3:11, 4:5, 4:7, 4:9, 4:10, 4:11, 4:13, 4:14, 4:15, 5:6, 5:7, 5:8, 5:9, 5:11,
:12, 5:13, 5:14, 5:16, 5:17, 5:18, or 5:19. In some formulations provided herein, the stoichiometric ratios
of the nicotine to acid are 1:1, 1:2, 1:3, or 1:4 (nicotine: acid).
[0175] In certain embodiments, the pH of the nicotine formulation is acidic. In certain embodiments,
the pH of the nicotine formulation is < 7.0. In certain embodiments, the pH of the nicotine formulation is
< 6.0. In certain embodiments, the pH of the nicotine formulation is < 5.0. In certain embodiments, the
pH of the nicotine formulation is < 4.0. In certain embodiments, the pH of the nicotine formulation is
>3.0. In certain embodiments, the pH of the nicotine formulation is >4.0. In certain embodiments, the pH
of the nicotine formulation is >5.0. In certain embodiments, the pH of the nicotine formulation is >6.0.
In certain embodiments, the vaporizable material contains organic material from a Cannabis
genus plant. In certain embodiments, the vaporizable material contains an extract from a Cannabis genus
plant. In certain embodiments, the vaporizable material contains a cannabinoid. In certain embodiments,
the cannabinoid is tetrahydrocannabinol (THC). In certain embodiments, the cannabinoid is
cannabigerolic acid (CBGA). In certain embodiments, the cannabinoid is cannabigerol (CBG). In certain
embodiments, the cannabinoid is tetrahydrocannabinolic acid (THCA). In certain embodiments, the
cannabinoid is cannabichromene (CBC). In certain embodiments, the cannabinoid is cannabicyclol
(CBL). In certain embodiments, the cannabinoid is cannabivarin (CBV). In certain embodiments, the
cannabinoid is cannabichromevarin (CBCV). In certain embodiments, the cannabinoid is
cannabigerovarin (CBGV). In certain embodiments, the cannabinoid is cannabigerol Monomethyl Ether
(CBGM). In certain embodiments, the cannabinoid is deltatetrahydrocannabinol (D8THC). In certain
embodiments, the cannabinoid is deltatetrahydrocannabinol (D9THC). In certain embodiments, the
cannabinoid is tetrahydrocannabivarin (THCV). In certain embodiments, the cannabinoid is cannabinolic
acid (CBNA). In certain embodiments, the cannabinoid is Cannabinol (CBN). In certain embodiments,
the cannabinoid is cannabidiolic acid (CBDA). In certain embodiments, the cannabinoid is
Cannabidivaric acid (CBDVA). In certain embodiments, the cannabinoid is cannabidiol (CBD). In certain
embodiments, the cannabinoid is cannabichromenic acid (CBCA). In certain embodiments, the
cannabinoid is Cannabichromene (CBC). In certain embodiments, the cannabinoid is cannabicyclolic acid
(CBLA). In certain embodiments, the cannabinoid is an stereo isomer of any of the above mentioned
cannabinoids. In certain embodiments, the cannabinoid is a salt of any of the above mentioned
cannabinoids.
In certain embodiments, the vaporizable material is a cannabinoid formulation. In certain
embodiments, the concentration of cannabinoid in the cannabinoid formulation is from 1-99%
cannabinoid. In certain embodiments, the concentration of cannabinoid in the cannabinoid formulation is
from 5-95% cannabinoid. In certain embodiments, the concentration of cannabinoid in the cannabinoid
formulation is from 10-90% cannabinoid. In certain embodiments, the concentration of cannabinoid in the
cannabinoid formulation exceeds about 99% cannabinoid. In certain embodiments, the concentration of
cannabinoid in the cannabinoid formulation exceeds about 98% cannabinoid. In certain embodiments, the
concentration of cannabinoid in the cannabinoid formulation exceeds about 97% cannabinoid. In certain
embodiments, the concentration of cannabinoid in the cannabinoid formulation exceeds about 96%
cannabinoid. In certain embodiments, the concentration of cannabinoid in the cannabinoid formulation
exceeds about 95% cannabinoid. In certain embodiments, the concentration of cannabinoid in the
cannabinoid formulation exceeds about 94% cannabinoid. In certain embodiments, the concentration of
cannabinoid in the cannabinoid formulation exceeds about 93% cannabinoid. In certain embodiments, the
concentration of cannabinoid in the cannabinoid formulation exceeds about 92% cannabinoid. In certain
embodiments, the concentration of cannabinoid in the cannabinoid formulation exceeds about 91%
cannabinoid. In certain embodiments, the concentration of cannabinoid in the cannabinoid formulation
exceeds about 90% cannabinoid. In certain embodiments, the concentration of cannabinoid in the
cannabinoid formulation exceeds about 80% cannabinoid. In certain embodiments, the concentration of
cannabinoid in the cannabinoid formulation exceeds about 70% cannabinoid. In certain embodiments, the
concentration of cannabinoid in the cannabinoid formulation exceeds about 60% cannabinoid. In certain
embodiments, the concentration of in the cannabinoid formulation exceeds about 50% cannabinoid. In
certain embodiments, the concentration of in the cannabinoid formulation exceeds about 40%
cannabinoid. In certain embodiments, the concentration of cannabinoid in the cannabinoid formulation
exceeds about 30% cannabinoid. In certain embodiments, the concentration of cannabinoid in the
cannabinoid formulation exceeds about 20% cannabinoid. In certain embodiments, the concentration of
cannabinoid in the cannabinoid formulation exceeds about 10% cannabinoid. In certain embodiments, the
concentration of cannabinoid in the cannabinoid formulation is from about 1% to about 10% cannabinoid.
In certain embodiments, the concentration of cannabinoid in the cannabinoid formulation is from about
% to about 20% cannabinoid. In certain embodiments, the concentration of cannabinoid in the
cannabinoid formulation is from about 20% to about 30% cannabinoid. In certain embodiments, the
concentration of cannabinoid in the cannabinoid formulation is from about 30% to about 40%
cannabinoid. In certain embodiments, the concentration of cannabinoid in the cannabinoid formulation is
from about 40% to about 50% cannabinoid. In certain embodiments, the concentration of cannabinoid in
the cannabinoid formulation is from about 50% to about 60% cannabinoid. In certain embodiments, the
concentration of cannabinoid in the cannabinoid formulation is from about 60% to about 70%
cannabinoid. In certain embodiments, the concentration of cannabinoid in the cannabinoid formulation is
from about 70% to about 80% cannabinoid. In certain embodiments, the concentration of cannabinoid in
the cannabinoid formulation is from about 80% to about 90% cannabinoid. In certain embodiments, the
concentration of cannabinoid in the cannabinoid formulation is from about 90% to about 100%
cannabinoid.
In certain embodiments, the pH of the cannabinoid formulation is acidic. In certain
embodiments, the pH of the cannabinoid formulation is < 7.0. In certain embodiments, the pH of the
cannabinoid formulation is < 6.0 In certain embodiments, the pH of the cannabinoid formulation is < 5.0.
In certain embodiments, the pH of the cannabinoid formulation is < 4.0. In certain embodiments, the pH
of the cannabinoid formulation is >3.0. In certain embodiments, the pH of the cannabinoid formulation is
>4.0. In certain embodiments, the pH of the cannabinoid formulation is >5.0. In certain embodiments, the
pH of the cannabinoid formulation is >6.0. In certain embodiments, the pH of the cannabinoid
formulation is basic. In certain embodiments, the pH of the cannabinoid formulation is < 10.0. In certain
embodiments, the pH of the cannabinoid formulation is < 9.0 In certain embodiments, the pH of the
cannabinoid formulation is < 8.0. In certain embodiments, the pH of the cannabinoid formulation is >7.0.
In certain embodiments, the pH of the cannabinoid formulation is >8.0. In certain embodiments, the pH of
the cannabinoid formulation is >9.0. In certain embodiments, the pH of the cannabinoid formulation is
>10.0.
In certain embodiments, the vaporizable material is a Cannabis formulation. In certain
embodiments, the concentration of the Cannabis formulation is from 1-99% Cannabis. In certain
embodiments, the concentration of the Cannabis formulation is from 5-95% Cannabis. In certain
embodiments, the concentration of the Cannabis formulation is from 10-90% Cannabis. In certain
embodiments, the Cannabis formulation exceeds about 99% Cannabis. In certain embodiments, the
Cannabis formulation exceeds about 98% Cannabis. In certain embodiments, the Cannabis formulation
exceeds about 97% Cannabis. In certain embodiments, the Cannabis formulation exceeds about 96%
Cannabis. In certain embodiments, the Cannabis formulation exceeds about 95% Cannabis. In certain
embodiments, the Cannabis formulation exceeds about 94% Cannabis. In certain embodiments, the
Cannabis formulation exceeds about 93% Cannabis. In certain embodiments, the Cannabis formulation
exceeds about 92% Cannabis. In certain embodiments, the Cannabis formulation exceeds about 91%
Cannabis. In certain embodiments, the Cannabis formulation exceeds about 90% Cannabis. In certain
embodiments, the Cannabis formulation exceeds about 80% Cannabis. In certain embodiments, the
Cannabis formulation exceeds about 70% Cannabis. In certain embodiments, the Cannabis formulation
exceeds about 60% Cannabis. In certain embodiments, the Cannabis formulation exceeds about 50%
Cannabis. In certain embodiments, the Cannabis formulation exceeds about 40% Cannabis. In certain
embodiments, the Cannabis formulation exceeds about 30% Cannabis. In certain embodiments, the
Cannabis formulation exceeds about 20% Cannabis. In certain embodiments, the Cannabis formulation
exceeds about 10% Cannabis.
In certain embodiments, the pH of the Cannabis formulation is acidic. In certain
embodiments, the pH of the Cannabis formulation is < 7.0. In certain embodiments, the pH of the
Cannabis formulation is < 6.0 In certain embodiments, the pH of the Cannabis formulation is < 5.0. In
certain embodiments, the pH of the Cannabis formulation is < 4.0. In certain embodiments, the pH of the
Cannabis formulation is >3.0. In certain embodiments, the pH of the Cannabis formulation is >4.0. In
certain embodiments, the pH of the Cannabis formulation is >5.0. In certain embodiments, the pH of the
Cannabis formulation is >6.0. In certain embodiments, the pH of the Cannabis formulation is basic. In
certain embodiments, the pH of the Cannabis formulation is < 10.0. In certain embodiments, the pH of
the Cannabis formulation is < 9.0 In certain embodiments, the pH of the Cannabis formulation is < 8.0.
In certain embodiments, the pH of the Cannabis formulation is >7.0. In certain embodiments, the pH of
the Cannabis formulation is >8.0. In certain embodiments, the pH of the Cannabis formulation is >9.0. In
certain embodiments, the pH of the Cannabis formulation is >10.0.
In certain embodiments, the vaporizable material contains a medicinal compound as an active
ingredient. The medicinal compounds that are active ingredients for vaporization with the electronic
vaporizer device utilizing the method herein, include drugs that can be heated without combustion to
vaporization for inhalation delivery at a temperature range of, e.g., about 100 °C (e.g., for water-based
carriers, e.g., about 100 °C , 105°C, 110°C, 120°C, 130°C, 140°C, 150°C, 160°C, 170°C, etc.; for
ethanol-based formulations, e.g., about 50°C, about 60°C, about 70°C, about 80°C, etc.) to about (e.g.,
below) the temperature at which the active ingredient thermally decomposes (e.g., less than about 150°C,
160°C, 170°C, 180°C, 190°C, 200°C, 210°C, 220°C, 230°C, 240°C, 250°C, 260°C, 270°C, 280°C,
290°C, 300°C, etc.). In certain embodiments, the drugs can be neat or are solubilized in a
pharmaceutically acceptable solvent. In certain embodiments, the drugs can include over the counter
(OTC) substances as aides for various ailments; wherein said drugs can include known respiratory aides
for asthma or chronic obstructive pulmonary disease (COPD). The vaporizable materials that are active
ingredients for vaporization with the device(s) herein described, can include drugs that can be heated to
vaporization for inhalation delivery, without combustion; wherein said drugs can include over the counter
(OTC) substances from the group comprising upper respiratory aides (like cetirizine), analgesics and
internal medication aides (like ibuprofen, naproxen), heartburn aides (like omeprazole), sleeping aides
(like doxylamine, diphenhydramine, melatonin), or motion sickness aides (like meclizine). In certain
embodiments, the vaporizable material can contain respiratory aides for asthma or chronic obstructive
pulmonary disease (COPD) such as short acting beta-agonist (like albuterol, levalbuterol, pirbuterol), long
acting beta-agonist (like salmeterol, formoterol), anti-cholinergics (like atropine sulfate, ipratropium
bromide), leukotriene modifiers (like montelukast, zafirlukast), cartico-steriods (like fluticasone,
budesonide, mometasone), theophylline (like theophylline), or combination corticosteroid and beta
agonist, long lasting (fluticasone and salmeterol, budesonide and formoterol, mometasone and
formoterol). In certain embodiments, the vaporizable material can contain botanicals and/or
nutraceuticals such as tea (polyphenols, flavonoids, green tea catechins +/- caffeine); horehound (phenol
flavonoid glycosides, labdane diterpenoids, yohimbe, cranberry/grape(proanthocyanidins), black cohosh
(terpene glycoside fraction (actine/cimifugoside), flax seed (omega fatty acids), echinacea (echinacoside),
valerian (alkaloids, gabapentin, isovaleric acid, terpenes), senna (senna cglycosides), cinnamon
(cinnamaldehyde, phenols, terpenes), vitamin D, saw palmetto (fatty acids), or caffeine. In certain
embodiments, the vaporizable material is soluble to at least fifty percent by weight in any suitable carrier
solvent such as glycols (such as propylene glycol and vegetable glycerin), ethylene glycol, dipropylene
glycol, trimethylene glycol, ethanol, and combinations thereof. In certain embodiments, the medicinal
compound is terpinolene. In certain embodiments, the medicinal compound is Linalool. In certain
embodiments, the medicinal compound is phytol, In certain embodiments, the medicinal compound is
beta myrcene. In certain embodiments, the medicinal compound is citronellol. In certain embodiments,
the medicinal compound is caryophyllene oxide. In certain embodiments, the medicinal compound is
alpha pinene. In certain embodiments, the medicinal compound is limonene. In certain embodiments, the
medicinal compound is beta caryophyllene. In certain embodiments, the medicinal compound is
humulene. In certain embodiments, the vaporizable material is an essential oil.
User Interface
[0182] In certain embodiments, the vaporizer apparatuses described herein may include a user
interface. In certain embodiments, the user interface is a display. In certain embodiments, the display is an
LCD. In certain embodiments, the display is an LED. In certain embodiments, the display is an OLED. In
certain embodiments, the display provides a user interface. In certain embodiments, the display is touch
sensitive. In certain embodiments, the display communicates puff frequency, puff duration, amount of
TPM vaporized, amount of active ingredient vaporized, or any combination thereof. In certain
embodiments, the display allows the user to select the type of vaporizable material. In certain
embodiments, the display allows the user to select the amount of vaporizable material vaporized before
the alert unit alerts the user or the vaporizer device is disabled, or both. In certain embodiments, the
electronic vaporizer device utilizing the method comprises a user interface controller. In certain
embodiments, the user interface controller is communicatively coupled to the display. In certain
embodiments, the user interface controller is a software module that controls information communicated
via the display.
In some embodiments, the user interface can be configured to allow a user to change and/or
monitor the settings and state of the electronic vaporizer device. For example, in one embodiment, user
control means can be used to limit the usage of the device, relative to any of calculated TPM, puff
duration, puff volume, voltage or heat temperature, singly or in combination.
Further, the vaporizer device described herein can include at least one of a switch, a keypad, a
display, an input/output port, and a wireless transceiver. In one embodiment, the input/output port and the
wireless transceiver can be employed to create a communications link between the control unit of the
electronic vaporizer device and an external computer, such as a cell phone or personal computer.
The foregoing disclosure and description of the invention are illustrative and explanatory
thereof and various adaptations may be made without departing from the spirit of the invention.
While preferred embodiments of the present invention have been shown and described
herein, it will be obvious to those skilled in the art that such embodiments are provided by way of
example only. It is not intended that the invention be limited by the specific examples provided within the
specification. While the invention has been described with reference to the aforementioned specification,
the descriptions and illustrations of the embodiments herein are not meant to be construed in a limiting
sense. Numerous variations, changes, and substitutions will now occur to those skilled in the art without
departing from the invention. Furthermore, it shall be understood that all aspects of the invention are not
limited to the specific depictions, configurations or relative proportions set forth herein which depend
upon a variety of conditions and variables. It should be understood that various alternatives to the
embodiments of the invention described herein may be employed in practicing the invention. It is
therefore contemplated that the invention shall also cover any such alternatives, modifications, variations
or equivalents.
Additional details pertinent to the present invention, including materials and manufacturing
techniques, may be employed as within the level of those with skill in the relevant art. The same may
hold true with respect to method-based aspects of the invention in terms of additional acts commonly or
logically employed. Also, it is contemplated that any optional feature of the inventive variations
described may be set forth and claimed independently, or in combination with any one or more of the
features described herein. Likewise, reference to a singular item includes the possibility that there are a
plurality of the same items present. More specifically, as used herein and in the appended claims, the
singular forms "a," "and," "said," and "the" include plural referents unless the context clearly dictates
otherwise. It is further noted that the claims may be drafted to exclude any optional element. As such,
this statement is intended to serve as antecedent basis for use of such exclusive terminology as "solely,"
"only" and the like in connection with the recitation of claim elements, or use of a "negative" limitation.
Unless defined otherwise herein, all technical and scientific terms used herein have the same meaning as
commonly understood by one of ordinary skill in the art to which this invention belongs. The breadth of
the present invention is not to be limited by the subject specification, but rather only by the plain meaning
of the claim terms employed.
When a feature or element is herein referred to as being "on" another feature or element, it
can be directly on the other feature or element or intervening features and/or elements may also be
present. In contrast, when a feature or element is referred to as being "directly on" another feature or
element, there are no intervening features or elements present. It will also be understood that, when a
feature or element is referred to as being "connected", "attached" or "coupled" to another feature or
element, it can be directly connected, attached or coupled to the other feature or element or intervening
features or elements may be present. In contrast, when a feature or element is referred to as being
"directly connected", "directly attached" or "directly coupled" to another feature or element, there are no
intervening features or elements present. Although described or shown with respect to one embodiment,
the features and elements so described or shown can apply to other embodiments. It will also be
appreciated by those of skill in the art that references to a structure or feature that is disposed "adjacent"
another feature may have portions that overlap or underlie the adjacent feature.
It will be further understood that the terms "comprises" and/or "comprising," when used in
this specification, specify the presence of stated features, steps, operations, elements, and/or components,
but do not preclude the presence or addition of one or more other features, steps, operations, elements,
components, and/or groups thereof. As used herein, the term "and/or" includes any and all combinations
of one or more of the associated listed items and may be abbreviated as "/".
Spatially relative terms, such as "under", "below", "lower", "over", "upper" and the like, may
be used herein for ease of description to describe one element or feature's relationship to another
element(s) or feature(s) as illustrated in the figures. It will be understood that the spatially relative terms
are intended to encompass different orientations of the device in use or operation in addition to the
orientation depicted in the figures. For example, if a device in the figures is inverted, elements described
as "under" or "beneath" other elements or features would then be oriented "over" the other elements or
features. Thus, the exemplary term "under" can encompass both an orientation of over and under. The
device may be otherwise oriented (rotated 90 degrees or at other orientations) and the spatially relative
descriptors used herein interpreted accordingly. Similarly, the terms "upwardly", "downwardly",
"vertical", "horizontal" and the like are used herein for the purpose of explanation only unless specifically
indicated otherwise.
Although the terms “first” and “second” may be used herein to describe various
features/elements (including steps), these features/elements should not be limited by these terms, unless
the context indicates otherwise. These terms may be used to distinguish one feature/element from another
feature/element. Thus, a first feature/element discussed below could be termed a second feature/element,
and similarly, a second feature/element discussed below could be termed a first feature/element without
departing from the teachings of the present invention.
Throughout this specification and the claims which follow, unless the context requires
otherwise, the word “comprise”, and variations such as “comprises” and “comprising” means various
components can be co-jointly employed in the methods and articles (e.g., compositions and apparatuses
including device and methods). For example, the term “comprising” will be understood to imply the
inclusion of any stated elements or steps but not the exclusion of any other elements or steps.
As used herein in the specification and claims, including as used in the examples and unless
otherwise expressly specified, all numbers may be read as if prefaced by the word "about" or
“approximately,” even if the term does not expressly appear. The phrase “about” or “approximately” may
be used when describing magnitude and/or position to indicate that the value and/or position described is
within a reasonable expected range of values and/or positions. For example, a numeric value may have a
value that is +/- 0.1% of the stated value (or range of values), +/- 1% of the stated value (or range of
values), +/- 2% of the stated value (or range of values), +/- 5% of the stated value (or range of values), +/-
10% of the stated value (or range of values), etc. Any numerical values given herein should also be
understood to include about or approximately that value, unless the context indicates otherwise. For
example, if the value "10" is disclosed, then "about 10" is also disclosed. Any numerical range recited
herein is intended to include all sub-ranges subsumed therein. It is also understood that when a value is
disclosed that "less than or equal to" the value, "greater than or equal to the value" and possible ranges
between values are also disclosed, as appropriately understood by the skilled artisan. For example, if the
value "X" is disclosed the "less than or equal to X" as well as "greater than or equal to X" (e.g., where X
is a numerical value) is also disclosed. It is also understood that the throughout the application, data is
provided in a number of different formats, and that this data, represents endpoints and starting points, and
ranges for any combination of the data points. For example, if a particular data point “10” and a particular
data point “15” are disclosed, it is understood that greater than, greater than or equal to, less than, less
than or equal to, and equal to 10 and 15 are considered disclosed as well as between 10 and 15. It is also
understood that each unit between two particular units are also disclosed. For example, if 10 and 15 are
disclosed, then 11, 12, 13, and 14 are also disclosed.
Although various illustrative embodiments are described above, any of a number of changes
may be made to various embodiments without departing from the scope of the invention as described by
the claims. For example, the order in which various described method steps are performed may often be
changed in alternative embodiments, and in other alternative embodiments one or more method steps may
be skipped altogether. Optional features of various device and system embodiments may be included in
some embodiments and not in others. Therefore, the foregoing description is provided primarily for
exemplary purposes and should not be interpreted to limit the scope of the invention as it is set forth in
the claims.
The examples and illustrations included herein show, by way of illustration and not of
limitation, specific embodiments in which the subject matter may be practiced. As mentioned, other
embodiments may be utilized and derived there from, such that structural and logical substitutions and
changes may be made without departing from the scope of this disclosure. Such embodiments of the
inventive subject matter may be referred to herein individually or collectively by the term “invention”
merely for convenience and without intending to voluntarily limit the scope of this application to any
single invention or inventive concept, if more than one is, in fact, disclosed. Thus, although specific
embodiments have been illustrated and described herein, any arrangement calculated to achieve the same
purpose may be substituted for the specific embodiments shown. This disclosure is intended to cover any
and all adaptations or variations of various embodiments. Combinations of the above embodiments, and
other embodiments not specifically described herein, will be apparent to those of skill in the art upon
reviewing the above description.
Claims (32)
1. A method of determining an estimated amount of a substance delivered to a user of a 5 vaporizer device, the method comprising: determining an amount of power applied to a heater of a vaporizer device, the heater configured to vaporize a vaporizable material; determining a first temperature of a portion of the vaporizer device at a first time; determining a second temperature of the portion of the vaporizer device at a second time, 10 subsequent to the first time; and determining, based on the amount of power applied to the heater and a difference between the first temperature and the second temperature, the estimated amount of the substance delivered to the user of the vaporizer device from the first time to the second time.
2. The method of claim 1, wherein the vaporizable material comprises the substance. 15
3. The method of claim 1 or 2, wherein the estimated amount of the substance comprises an estimated amount of an active ingredient delivered to the user.
4. The method of any one of claims 1 to 3, wherein the vaporizable material comprises nicotine and a carrier.
5. The method of claim 4, wherein the carrier comprises one or more glycols. 20
6. The method of any one of claims 1 to 5, wherein the first time is at a beginning of a time period, wherein the second time is at an end of the time period, and wherein the estimated amount of the substance delivered to the user comprises an estimate of an amount of the substance delivered during the time period.
7. The method of any one of claims 1 to 6, further comprising: 25 detecting a user puff on the vaporizer device, wherein the first time corresponds to a start time of the user puff, and wherein the second time corresponds to an end time of the user puff.
8. The method of any one of claims 1 to 5, wherein the determining the estimated amount of the substance delivered to the user of the vaporizer device comprises determining a first estimated amount of the substance delivered to the user of the vaporizer device during a first time period within a session of use of the vaporizer device; and 5 wherein the method further comprises: determining a plurality of estimated amounts of the substance delivered to the user, each of the plurality of estimated amounts corresponding to one of a plurality of sequential time periods occurring after the first time period within the session of use of the vaporizer device, each of the plurality of estimated amounts of the substance based on an estimated power applied to the 10 heater during a corresponding one of the plurality of sequential time periods, an estimated temperature of the vaporizable material at a beginning of the corresponding one of the plurality of sequential time periods, and an estimated temperature of the vaporizable material at an end of the corresponding one of the plurality of sequential time periods; and determining, based on a sum of the first estimated amount of the substance and the 15 plurality of estimated amounts of the substance, a total estimated amount of the substance delivered to the user over the session of use of the vaporizer device.
9. The method of claim 8, wherein the determining the total estimated amount of the substance delivered comprises aggregating the first estimated amount of the substance and each of the plurality of estimated amounts of the substance as the first estimated amount of the substance and each of 20 the plurality of estimated amounts of the substance are determined.
10. The method of any one of claims 1 to 9, wherein the determining the estimated amount of the substance delivered comprises: calculating, based on a first constant multiplied by the difference between the first temperature and the second temperature, a first value; 25 calculating, based on a second constant multiplied by the second temperature, a second value; calculating, based on the power applied to the heater subtracted by both the first value and the second value, a third value; and calculating, based on a third constant multiplied by the third value, the estimated amount 30 of the substance delivered.
11. The method of any one of claims 1 to 5, further comprising: causing disabling of the vaporizer device based on determining that a total estimated amount of the substance delivered, over a time period, meets or exceeds a preset threshold, the total estimated amount of the substance delivered comprising the estimated amount of the substance delivered from the first time to the second time and one or more other estimated amounts of the substance delivered to the user within the time period.
12. The method of any one of claims 1 to 5, further comprising 5 causing alerting to the user based on determining that a total estimated amount of the substance delivered, over a time period, meets or exceeds a preset threshold, the total estimated amount of the substance delivered comprising the estimated amount of the substance delivered from the first time to the second time and one or more other estimated amounts of the substance delivered to the user within the time period. 10
13. The method of any one of claims 1 to 12, wherein determining the first temperature comprises calculating, based on an electrical property of the heater that is proportional to a temperature of the heater, an estimate of the first temperature.
14. The method of any one of claims 1 to 13, wherein the portion of the vaporizer device comprises one or more of the heater and the vaporizable material.
15 15. The method of any one of claims 1 to 14, further comprising: transmitting, by the vaporizer device to a separate device for displaying information related to the estimated amount of the substance, one or more of the amount of power applied to the heater, the first temperature, and the second temperature.
16. A vaporizer device comprising: 20 a heater configured to vaporize a vaporizable material; and one or more controllers configured to perform operations, the operations comprising: determining an amount of power applied to a heater, the heater configured to vaporize a vaporizable material; determining a first temperature of a portion of the vaporizer device at a first time; 25 determining a second temperature of the portion of the vaporizer device at a second time, subsequent to the first time; and determining, based on the amount of power applied to the heater and a difference between the first temperature and the second temperature, an estimated amount of a substance delivered to a user from the first time to the second time. 30
17. The vaporizer device of claim 16, wherein the vaporizable material comprises the substance.
18. The vaporizer device of claim 16 or 17, wherein the estimated amount of the substance comprises an amount estimated of an active ingredient delivered to the user.
19. The vaporizer device of any of claims 16 to 18, wherein the vaporizable material comprises nicotine and a carrier. 5
20. The vaporizer device of claim 19, wherein the carrier comprises one or more glycols.
21. The vaporizer device of any of claims 16 to 20, wherein the first time is at a beginning of a time period, wherein the second time is at an end of the time period, and wherein the estimated amount of the substance delivered to the user comprises an estimate of an amount of the substance delivered during the time period. 10
22. The vaporizer device of any of claims 16 to 21, wherein the operations further comprise: detecting a user puff on the vaporizer device, wherein the first time corresponds to a start time of the user puff, and wherein the second time corresponds to an end time of the user puff.
23. The vaporizer device of any of claims 16 to 20, wherein the determining the estimated amount of the substance delivered to the user of the vaporizer device comprises determining a first 15 estimated amount of the substance delivered to the user of the vaporizer device during a first time period within a session of use of the vaporizer device; and wherein the operations further comprise: determining a plurality of estimated amounts of the substance delivered to the user, each of the plurality of estimated amounts corresponding to one of a plurality of sequential time 20 periods occurring after the first time period within the session of use of the vaporizer device, each of the plurality of estimated amounts of the substance based on an estimated power applied to the heater during a corresponding one of the plurality of sequential time periods, an estimated temperature of the vaporizable material at a beginning of the corresponding one of the plurality of sequential time periods, and an estimated temperature of the vaporizable material at an end of the 25 corresponding one of the plurality of sequential time periods; and determining, based on a sum of the first estimated amount of the substance and the plurality of estimated amounts of the substance, a total estimated amount of the substance delivered to the user over the session of use of the vaporizer device.
24. The vaporizer device of claim 23, wherein the determining the total estimated amount of 30 the substance delivered comprises aggregating the first estimated amount of the substance and each of the plurality of estimated amounts of the substance as the first estimated amount of the substance and each of the plurality of estimated amounts of the substance are determined.
25. The vaporizer device of any of claims 16 to 24, wherein the determining the estimated amount of the substance delivered comprises: calculating, based on a first constant multiplied by the difference between the first temperature and the second temperature, a first value; 5 calculating, based on a second constant multiplied by the second temperature, a second value; calculating, based on the power applied to the heater subtracted by both of the first value and the second value, a third value; and calculating, based on a third constant multiplied by the third value, the estimated amount 10 of the substance delivered.
26. The vaporizer device of any of claims 16 to 20, wherein the operations further comprise: causing disabling of the vaporizer device based on determining that a total estimated amount of the substance delivered, over a time period, meets or exceeds a preset threshold, the total estimated amount of the substance delivered comprising the estimated amount of the 15 substance delivered from the first time to the second time and one or more other estimated amounts of the substance delivered to the user within the time period.
27. The vaporizer device of any of claims 16 to 20, wherein the operations further comprise: causing alerting to the user based on determining that a total estimated amount of the substance delivered, over a time period, meets or exceeds a preset threshold, the total estimated 20 amount of the substance delivered comprising the estimated amount of the substance delivered from the first time to the second time and one or more other estimated amounts of the substance delivered to the user within the time period.
28. The vaporizer device of any of claims 16 to 27, wherein the determining the first temperature comprises calculating, based on an electrical property of the heater that is proportional to a 25 temperature of the heater, an estimate of the first temperature.
29. The vaporizer device of any of claims 16 to 28, wherein the portion of the vaporizer device comprises one or more of the heater and the vaporizable material.
30. The vaporizer device of any of claims 16 to 29, wherein the one or more controllers comprise one or more of operating logic and software instructions. 30
31. The method of any of claims 1 to 5, wherein the determining the estimated amount of the substance delivered to the user of the vaporizer device comprises determining a first estimated amount of the substance delivered to the user of the vaporizer device during a first time period; and wherein the method further comprises: determining, for a second time period, a second estimated amount of the substance delivered to the user, the second estimated amount based on an estimated power applied to the heater during the second time period, an estimated temperature of the vaporizable material at a 5 beginning of the second time period, and an estimated temperature of the vaporizable material at an end of the second time period; and determining, based on a sum of the first estimated amount of the substance and the second amount of the substance, a total estimated amount of the substance delivered to the user over the first time period and the second time period.
32. The vaporizer device of any of claims 16 to 31, wherein the determining the estimated amount of the substance delivered to the user of the vaporizer device comprises determining a first estimated amount of the substance delivered to the user of the vaporizer device during a first time period; 15 wherein the operations further comprise: determining, for a second time period, a second estimated amount of the substance delivered to the user, the second estimated amount based on an estimated power applied to the heater during the second time period, an estimated temperature of the vaporizable material at a beginning of the second time period, and an estimated temperature of the vaporizable material at an end of the second time period; 20 and determining, based on a sum of the first estimated amount of the substance and the second amount of the substance, a total estimated amount of the substance delivered to the user over the first time period and the second time period.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462088464P | 2014-12-05 | 2014-12-05 | |
US62/088,464 | 2014-12-05 | ||
US201562199828P | 2015-07-31 | 2015-07-31 | |
US62/199,828 | 2015-07-31 | ||
PCT/US2015/064088 WO2016090303A1 (en) | 2014-12-05 | 2015-12-04 | Calibrated dose control |
Publications (2)
Publication Number | Publication Date |
---|---|
NZ732534A NZ732534A (en) | 2021-07-30 |
NZ732534B2 true NZ732534B2 (en) | 2021-11-02 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2021218151B2 (en) | Calibrated dose control | |
EP3503750B1 (en) | Inhalation device with metering | |
RU2721064C2 (en) | Flow-controlled inhaler | |
US20180263288A1 (en) | Method and apparatus for cloud integration control of medicine delivery parameters in an electronic vaporizer | |
US20190364974A1 (en) | Vaporization device delivering metered amount of medicant from non-dosage form source | |
CA3090359A1 (en) | Method and inhaler for providing two or more substances by inhalation | |
US11633554B1 (en) | Adaptive systems and methods for delivery of a medicament | |
US20200187564A1 (en) | Inhalation device for use with nicotine products with controlled shutoff | |
US20230309628A1 (en) | Inhalation device with cylindrical rotatable dial for input of a target amount of inhaled substance | |
RU2801277C2 (en) | Method for determining the dose of evaporating material (variants) | |
NZ732534B2 (en) | Calibrated dose control | |
WO2021011879A1 (en) | Inhalation devices with dosage metering and compatible with standard connection systems |